[{"text": "Glucotrack Announces ISO 13485:2016 Certification Glucotrack, Inc. Tue, Jan 21, 2025, 4:01 PM 4 min read In This Article: GCTK -10.94% Glucotrack, Inc. ISO Certification highlights commitment to quality for continuous blood glucose monitor RUTHERFORD, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (\u201cGlucotrack\u201d or the \u201cCompany\u201d), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it has received ISO 13485:2016 certification from the British Standards Institute (BSI). \u201cThis ISO certification is a major step in our journey toward delivering high-quality products,\u201d said Paul V. Goode, PhD, President and Chief Executive Officer. \u201cMeeting these rigorous global standards for design and manufacturing demonstrates our dedication to quality and regulatory excellence as we continue to achieve clinical and developmental milestones for our revolutionary Continuous Blood Glucose Monitor (CBGM) for people with diabetes.\u201d The Company successfully completed Stage I and Stage II Assessments performed by the notified body, BSI, to verify it has established, and is maintaining, a quality management system that meets all requirements of the ISO 13485:2016 standard for design and development of the Company\u2019s products. ISO 13485 is an internationally recognized standard for quality management systems, created by the International Organization for Standardization to ensure the safety and effectiveness of medical devices. It builds on the ISO 9001 standard with additional regulatory requirements specific to medical devices. In 2024, the U.S. Food and Drug Administration issued the Quality Management System Regulation (QMSR) Final Rule, which harmonizes U.S. requirements with global standards through the adoption of ISO 13485 for medical devices. ISO 13485 is also strongly recommended and widely used in the European Union. For more information about Glucotrack\u2019s CBGM, visit glucotrack.com . Information on the Company\u2019s website does not constitute a part of and is not incorporated by reference into this press release. About\u00a0Glucotrack, Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack\u2019s CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. For more information, please visit http://www.glucotrack.com . Story Continues Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as \u201cbelieve\u201d, \u201cexpect\u201d, \u201cplan\u201d and \u201cwill\u201d are intended to identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, management. These statements relate only to events as of the date on which the statements are made, and Glucotrack undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. All of the forward-looking statements made in this press release are qualified by these cautionary statements, and there can be no assurance that the actual results anticipated by Glucotrack will be realized or, even if substantially realized, that they will have the expected consequences to or effects on us or our business or operations. Readers are cautioned that certain important factors may affect Glucotrack\u2019s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect Glucotrack\u2019s results include, but are not limited to, the ability of Glucotrack to raise additional capital to finance its operations (whether through public or private equity offerings, debt financings, strategic collaborations or otherwise); risks relating to the receipt (and timing) of regulatory approvals (including U.S. Food and Drug Administration approval); risks relating to enrollment of patients in, and the conduct of, clinical trials; risks relating to Glucotrack\u2019s future distribution agreements; risks relating to its ability to hire and retain qualified personnel, including sales and distribution personnel; and the additional risk factors described in Glucotrack\u2019s filings with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d), including its Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the SEC on March 28, 2024. Contacts: Investor Relations: investors@glucotrack.com Media: GlucotrackPR@icrinc.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GCTK", "date": "2025-01-21T13:01:00+00:00", "sentiment": {"score": 0.13199036568403244, "confidence": 0.14168067276477814, "probabilities": {"positive": 0.14168067276477814, "negative": 0.009690307080745697, "neutral": 0.8486290574073792}}, "embedding": [-0.13936316967010498, -0.028364457190036774, -0.17332211136817932, -0.011735523119568825, -0.022190216928720474, -0.12643638253211975, -0.04828061908483505, 0.14781758189201355, -0.005992285907268524, -0.09663915634155273, -0.008289594203233719, 0.005988163407891989, -0.00042478181421756744, 0.09259765595197678, -0.18373245000839233, -0.13347914814949036, 0.0699416771531105, 0.04339711740612984, -0.16543364524841309, -0.04339420422911644, 0.025651821866631508, 0.12095663696527481, 0.059609219431877136, 0.1278015822172165, -0.12111926078796387, -0.08983135223388672, -0.08319148421287537, -0.12074233591556549, -0.08584011346101761, -0.08559448271989822, -0.06556832790374756, 0.001563575118780136, 0.1718202531337738, -0.05298495665192604, 0.0018953958060592413, 0.14720788598060608, -0.03144484758377075, -0.13921836018562317, -0.11901749670505524, -0.12357291579246521, 0.027954917401075363, -0.18967869877815247, -0.06433083117008209, 0.17093026638031006, 0.009593650698661804, 0.006098171696066856, -0.1200399100780487, 0.0013719575945287943, -0.10540707409381866, 0.10453559458255768, -0.03050941228866577, -0.03641148656606674, -0.012692105025053024, 0.09675953537225723, 0.06767380237579346, -0.010205291211605072, -0.1706487238407135, -0.07173359394073486, -0.033231716603040695, 0.09957122802734375, -0.0498507134616375, -0.02495914325118065, -0.09769736975431442, -0.006801886484026909, 0.14979861676692963, 0.01123260147869587, 0.043501172214746475, -0.08417783677577972, 0.025358133018016815, -0.04364834725856781, -0.041732631623744965, -0.10190658271312714, -0.012234993278980255, 0.17323660850524902, -0.08496414870023727, 0.22532349824905396, -0.08335046470165253, 0.15986782312393188, 0.11466355621814728, -0.07188484072685242, 0.14531943202018738, 0.045504070818424225, 0.1334846317768097, 0.05478867143392563, 0.028579868376255035, -0.08609316498041153, -0.03364953771233559, 0.16589361429214478, -0.12447336316108704, -0.03975140303373337, 0.09613118320703506, 0.011112104170024395, 0.0022262241691350937, 0.06847335398197174, 0.005721732974052429, -0.04377858340740204, 0.03806789219379425, -0.07593851536512375, 0.09429622441530228, 0.023903273046016693, -0.055223818868398666, -0.050811752676963806, -0.10269085317850113, 0.029292868450284004, -0.07253009080886841, -0.11476100236177444, 0.08011171221733093, 0.04659450799226761, 0.15440243482589722, 0.03649192303419113, -0.07807162404060364, 0.12502193450927734, -0.031202154234051704, -0.1522873044013977, -0.06539169698953629, 0.11019404232501984, -0.016224615275859833, 0.05021163821220398, 0.22226297855377197, -0.015588879585266113, 0.01242028083652258, -0.019268963485956192, 0.002711297944188118, -0.184334397315979, 0.10647745430469513, 0.07806001603603363, 0.10767707228660583, 5.657597372500052e-33, -0.005148932337760925, 0.025744576007127762, 0.05075256526470184, -0.08536515384912491, -0.10248589515686035, 0.0762939602136612, -0.019579894840717316, 0.030245184898376465, 0.04233716428279877, -0.03778301924467087, -0.1007702574133873, 0.09668600559234619, -0.1890876442193985, 0.14506128430366516, -0.00027948617935180664, 0.024017689749598503, -0.05706726759672165, 0.05812406912446022, 0.04523041844367981, 0.06822045147418976, 0.04212656617164612, -0.000352347269654274, 0.019713561981916428, 0.09119080752134323, 0.06987150758504868, 0.14139017462730408, -0.1094369888305664, 0.08029933273792267, -0.05084831267595291, 0.059039562940597534, 0.02923029474914074, 0.08729489892721176, 0.01989375241100788, -0.07145440578460693, -0.0744941234588623, -0.0963214859366417, -0.12821301817893982, -0.10476198047399521, 0.01580437272787094, 0.0038209939375519753, -0.018354300409555435, 0.059661343693733215, -0.0735078752040863, -0.07314732670783997, 0.1432073712348938, 0.1060228943824768, -0.022150471806526184, 0.0029179241973906755, 0.08583207428455353, 0.04654110223054886, -0.08990311622619629, 0.024765878915786743, -0.05754034221172333, -0.06802360713481903, 0.052000850439071655, 0.0003110496327280998, 0.04034668579697609, -0.05951886624097824, 0.028737694025039673, 0.12394535541534424, -0.06928476691246033, 0.30837777256965637, -0.01618059352040291, 0.011481177993118763, -0.05788292735815048, 0.07783880829811096, -0.1333141326904297, -0.07261723279953003, -0.13421286642551422, 0.0010482030920684338, -0.08504384011030197, 0.032877638936042786, -0.008418876677751541, 0.018267881125211716, -0.023380408063530922, -0.13341814279556274, -0.0029668379575014114, 0.11270111799240112, -0.05414120480418205, -0.10368373245000839, -0.04381537437438965, 0.1707039773464203, 0.0029573175124824047, -0.11130766570568085, -0.1289975345134735, 0.005843851715326309, -0.019158711656928062, 0.10337208956480026, -0.10707522928714752, -0.03605804592370987, -0.08701512217521667, 0.12393544614315033, 0.012308506295084953, 0.21021988987922668, 0.017138300463557243, -7.017829109419708e-33, 0.08651559799909592, -0.04560290277004242, 0.06887134909629822, 0.007137714885175228, 0.029929034411907196, -0.0732281506061554, 0.014279569499194622, -0.1572878509759903, 0.1398586481809616, 0.03312034159898758, 0.16131624579429626, 0.06793397665023804, 0.03168458119034767, 0.11183986067771912, -0.03303246945142746, 0.0871315747499466, -0.21876311302185059, -0.002752606989815831, -0.09935098886489868, 0.03336264193058014, -0.0011208769865334034, 0.20661619305610657, -0.04664146900177002, 0.011464757844805717, 0.08058753609657288, -0.05354495719075203, 0.05996903404593468, 0.08143346011638641, 0.14183452725410461, -0.10058790445327759, -0.011397252790629864, -0.05945107340812683, -0.17855511605739594, 0.07714919745922089, 0.08011693507432938, -0.25553420186042786, 0.06431622803211212, -0.08466970175504684, -0.045977670699357986, -0.08029504865407944, 0.0956098735332489, 0.12845714390277863, -0.12640835344791412, -0.017303239554166794, 0.07052289694547653, 0.02215159684419632, 0.10020402818918228, -0.12849479913711548, -0.003196612000465393, -0.17012616991996765, 0.08487709611654282, 0.024106912314891815, -0.07665617763996124, 0.09572012722492218, -0.04176925867795944, 0.06889602541923523, -0.058980122208595276, 0.0033454163931310177, -0.0609019473195076, -0.03115934319794178, 0.0706392228603363, -0.0036840979009866714, 0.020490694791078568, 0.044092439115047455, 0.15047189593315125, 0.07418633997440338, 0.13615782558918, 0.053081728518009186, 0.09123560786247253, 0.08779103308916092, -0.0193299762904644, -0.1607995629310608, -0.02578889951109886, -0.034778252243995667, 0.06502683460712433, -0.0338674932718277, -0.08399572223424911, -0.06268709897994995, -0.198360875248909, -0.10266860574483871, 0.006776161026209593, 0.03617795929312706, -0.010224476456642151, 0.04102238640189171, 0.10806365311145782, -0.029477789998054504, 0.009073762223124504, 0.00020663999021053314, 0.0037935192231088877, 0.15990421175956726, -0.14614257216453552, 0.054317936301231384, -0.1379273235797882, 0.1218729093670845, 0.049681417644023895, -9.99940752421935e-08, 0.05824775621294975, 0.009067172184586525, -0.11698414385318756, -0.042138516902923584, 0.003775916062295437, -0.07017642259597778, -0.07949439436197281, 0.014413014985620975, -0.03454749658703804, 0.13385076820850372, 0.05103529989719391, 0.1604686677455902, -0.14029529690742493, -0.014985732734203339, -0.027624420821666718, -0.007622673641890287, -0.09350582212209702, 0.15091609954833984, 0.012601307593286037, 0.1821332722902298, -0.022243378683924675, -0.028902150690555573, 0.058753643184900284, -0.06817546486854553, -0.08081468939781189, -0.09683047980070114, 0.14038574695587158, 0.1072545275092125, 0.04582270234823227, -0.056771643459796906, 0.12039176374673843, 0.046118877828121185, 0.10497765988111496, 0.008899478241801262, -0.08118313550949097, -0.013793161138892174, 0.00360683910548687, 0.06239929050207138, 0.08656421303749084, 0.12853169441223145, -0.039579421281814575, -0.06978941708803177, -0.04494091868400574, 0.03775324672460556, -0.021223004907369614, -0.15096327662467957, -0.08196667581796646, -0.014736620709300041, -0.0291421040892601, 0.12375892698764801, -0.083952397108078, -0.08522585034370422, -0.04416470229625702, -0.07058611512184143, 0.12152902036905289, -0.04531257599592209, -0.0369662269949913, -0.04775860160589218, -0.052628036588430405, -0.06228267401456833, 0.1605912148952484, -0.14754539728164673, 0.22170770168304443, 0.04068760573863983], "changes": {"1wk": -26.88000202178955}}, {"text": "Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs Glucotrack, Inc. Wed, Jan 15, 2025, 4:01 PM 4 min read In This Article: GCTK -10.94% Glucotrack, Inc. New hire set to drive clinical development and U.S. commercialization of the continuous blood glucose monitor for people with diabetes RUTHERFORD, N.J., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (\u201cGlucotrack\u201d or the \u201cCompany\u201d), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that Ted Williams has been named Vice President of Regulatory Affairs, effective immediately. Mr. Williams has nearly 25 years of experience and a proven track record of successful management of Regulatory Affairs and Quality Assurance for highly complex Class III medical devices including active, long term implantable continuous glucose monitors (\u201cCGM\u201d), drug/device combination products, in-dwelling catheter based endovascular temperature control modules and cardiovascular biopharmaceutical drug development within the 510(k), De Novo, Premarket Approval and Biologics License Application Regulatory pathways. He served as Vice President, Regulatory Affairs/Quality Assurance for Glysens Inc, a technology innovator focused on development of an implantable CGM. Prior to that, his experience includes roles with Therapeutics Inc. and Cardium Therapeutics focusing on oral and injectable drugs, biologics, medical devices and gene therapy. \u201cI am honored to join the Company at this pivotal time as we advance our human clinical trials and create a strategic regulatory program for the Continuous Blood Glucose Monitor (CBGM),\u201d said Mr. Williams. Paul V. Goode, PhD, President and Chief Executive Officer of Glucotrack, said: \u201cMr. Williams brings extensive knowledge and experience in navigating regulatory pathways to Glucotrack, which will be instrumental as we progress development of our CBGM through the Food and Drug Administration and beyond. We are thrilled to welcome him to the team as we work to bring this technology closer to the millions of people living with diabetes.\u201d For more information about Glucotrack\u2019s CBGM, visit glucotrack.com . Information on the Company\u2019s website does not constitute a part of and is not incorporated by reference into this press release. About\u00a0Glucotrack, Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack\u2019s CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. For more information, please visit http://www.glucotrack.com . Story Continues Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as \u201cbelieve\u201d, \u201cexpect\u201d, \u201cplan\u201d and \u201cwill\u201d are intended to identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, management. These statements relate only to events as of the date on which the statements are made, and Glucotrack undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. All of the forward-looking statements made in this press release are qualified by these cautionary statements, and there can be no assurance that the actual results anticipated by Glucotrack will be realized or, even if substantially realized, that they will have the expected consequences to or effects on us or our business or operations. Readers are cautioned that certain important factors may affect Glucotrack\u2019s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect Glucotrack\u2019s results include, but are not limited to, the ability of Glucotrack to raise additional capital to finance its operations (whether through public or private equity offerings, debt financings, strategic collaborations or otherwise); risks relating to the receipt (and timing) of regulatory approvals (including U.S. Food and Drug Administration approval); risks relating to enrollment of patients in, and the conduct of, clinical trials; risks relating to Glucotrack\u2019s future distribution agreements; risks relating to its ability to hire and retain qualified personnel, including sales and distribution personnel; and the additional risk factors described in Glucotrack\u2019s filings with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d), including its Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the SEC on March 28, 2024. Contacts: Investor Relations: investors@glucotrack.com Lisa Wilson In-Site Communications T: 917-543-9932 E: lwilson@insitecony.com Media: GlucotrackPR@icrinc.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GCTK", "date": "2025-01-15T13:01:00+00:00", "sentiment": {"score": 0.17412045039236546, "confidence": 0.18305952847003937, "probabilities": {"positive": 0.18305952847003937, "negative": 0.008939078077673912, "neutral": 0.8080013990402222}}, "embedding": [-0.13562139868736267, 0.011064648628234863, -0.14355067908763885, -0.05697803199291229, -0.04626619070768356, -0.05784722790122032, 0.03791482374072075, 0.14621827006340027, -0.00010041892528533936, -0.01999576762318611, -0.201402485370636, 0.046100519597530365, -0.06856699287891388, 0.12847396731376648, -0.13210804760456085, -0.05502308905124664, 0.03320100158452988, 0.09739470481872559, -0.12738840281963348, 0.01069008931517601, 0.003862478770315647, 0.08330702036619186, 0.06547843664884567, 0.009076086804270744, -0.15706250071525574, -0.06509903073310852, -0.04884461313486099, -0.13619568943977356, -0.10419264435768127, -0.03607640787959099, -0.04387752711772919, 0.025937609374523163, 0.13134704530239105, 0.019430287182331085, 0.0020400527864694595, 0.12183729559183121, -0.13503500819206238, -0.03780209645628929, -0.10494276136159897, -0.08910584449768066, 0.0638558566570282, -0.13060322403907776, -0.06588690727949142, 0.09881870448589325, -0.06901724636554718, -0.06390460580587387, -0.04429013654589653, 0.004375106655061245, -0.04903239756822586, 0.11841192841529846, -0.06665761768817902, -0.07393809407949448, 0.04104074463248253, -0.04042031615972519, 0.02322208508849144, 0.006045992020517588, -0.1324809044599533, -0.06359408050775528, 0.053359244018793106, 0.025170564651489258, 0.012480654753744602, -0.0009743241243995726, -0.1296006143093109, 0.03867630660533905, -0.001333774533122778, 0.003054776694625616, -0.00792346429079771, -0.02883705124258995, 0.010552745312452316, -0.08913953602313995, -0.009666702710092068, -0.009027738124132156, -0.04265797138214111, 0.04789847135543823, -0.016517924144864082, 0.15585611760616302, 0.025470120832324028, 0.19923332333564758, 0.17491333186626434, -0.14992961287498474, 0.21977990865707397, 0.004130006767809391, 0.13054899871349335, 0.09130816161632538, -0.06204260513186455, 0.014065805822610855, -0.06539125740528107, 0.13088655471801758, -0.08891037106513977, -0.001313396729528904, 0.12460409104824066, -0.012476785108447075, 0.0749300867319107, -0.01326702069491148, -0.1110982894897461, 0.022172490134835243, -0.0411444827914238, -0.08912286162376404, -0.003670182079076767, 0.03836352750658989, -0.058067113161087036, -0.05809881538152695, 0.026760360226035118, 0.09464473277330399, -0.055677078664302826, -0.09170037508010864, 0.054227642714977264, 0.01475481130182743, 0.11307431012392044, 0.03408852964639664, -0.04306907206773758, 0.20225843787193298, 0.016909440979361534, -0.07519969344139099, -0.0928414911031723, 0.13675783574581146, -0.1224108412861824, 0.07302194833755493, 0.19494350254535675, 0.021258577704429626, 0.009504507295787334, 0.046462737023830414, -0.06017044186592102, -0.15351171791553497, 0.06723435968160629, 0.05738279968500137, 0.09217259287834167, 6.787906822502684e-33, 0.05804787948727608, 0.001756196841597557, 0.07554063200950623, -0.03633453696966171, -0.0529366098344326, 0.1769966185092926, 0.03133678808808327, -0.04026217758655548, 0.003044305369257927, -0.06370775401592255, -0.07908960431814194, 0.0973847359418869, -0.06967365741729736, 0.14873728156089783, -0.15630894899368286, -0.028509002178907394, -0.062327660620212555, -0.02781684137880802, 0.021825464442372322, 0.026857737451791763, 0.010521788150072098, 0.08232418447732925, -0.07167146354913712, 0.12295427918434143, 0.002598748542368412, 0.0716792494058609, -0.11462351679801941, 0.07868890464305878, 0.04522426426410675, 0.09295913577079773, -0.10965519398450851, 0.0746714174747467, 0.050831668078899384, 0.00889878161251545, 0.05478265509009361, -0.07486173510551453, -0.10516749322414398, -0.15070538222789764, 0.051223788410425186, 0.009469322860240936, -0.029926780611276627, 0.0690787136554718, -0.06376736611127853, -0.060930535197257996, -0.08847784996032715, 0.028974950313568115, 0.04610293731093407, 0.0803065374493599, 0.08662949502468109, 0.026410087943077087, -0.012142357416450977, 0.0191146619617939, -0.026523560285568237, -0.09348580241203308, -0.016785914078354836, -0.021861083805561066, -0.041682783514261246, -0.017673874273896217, 0.08330272138118744, 0.03415137529373169, -0.025098983198404312, 0.2258094698190689, -0.06157081574201584, 0.050455302000045776, -0.0683521032333374, -0.004102639853954315, -0.16103187203407288, -0.06266183406114578, -0.07626324892044067, 0.031232107430696487, -0.027062853798270226, 0.0574868768453598, -0.005873069167137146, -0.006272353231906891, -0.06466583162546158, -0.08676367998123169, 0.07362832874059677, 0.17379486560821533, -0.12086363881826401, -0.00447264825925231, 0.0058035897091031075, 0.07909148931503296, -0.005148204974830151, -0.09812472760677338, -0.10548515617847443, -0.018157072365283966, -0.011428151279687881, -0.011126240715384483, -0.11311940103769302, 0.01170435082167387, -0.0803452581167221, 0.0487658828496933, 0.031103380024433136, 0.17994199693202972, 0.022301647812128067, -1.1190012678161192e-32, 0.0016801825258880854, -0.09363800287246704, 0.15553711354732513, -0.04882979020476341, 0.06464700400829315, -0.0005222856998443604, 0.10987719893455505, -0.22626781463623047, 0.09317917376756668, -0.035920314490795135, 0.0788184329867363, 0.1701890528202057, 0.02160508558154106, 0.016841989010572433, -0.028561221435666084, 0.08053653687238693, -0.13932767510414124, -0.014590942300856113, -0.1565241813659668, 0.023674562573432922, 0.008398673497140408, 0.23609289526939392, -0.10146886110305786, 0.021281927824020386, -0.011168627068400383, -0.05240517109632492, 0.05314638838171959, 0.07507631182670593, 0.04144129529595375, -0.010830082930624485, -0.007746947463601828, 0.011646416038274765, -0.23132655024528503, 0.04594827815890312, 0.017317572608590126, -0.14729559421539307, 0.03396175801753998, -0.0831054225564003, -0.025230886414647102, -0.1348823457956314, 0.17702528834342957, 0.0751771479845047, -0.017297808080911636, 0.009709371253848076, 0.1502176970243454, 0.03384198620915413, 0.017263587564229965, -0.05014915019273758, -0.05139054358005524, -0.03894787281751633, -0.16104789078235626, 0.04046209529042244, -0.07435387372970581, 0.022478139027953148, -0.03560842201113701, -0.0036087464541196823, 0.09630103409290314, -0.04018976539373398, 0.014539498835802078, -0.022289982065558434, -0.024042759090662003, -0.0299006886780262, 0.09214847534894943, 0.02970937266945839, 0.09691950678825378, 0.09986461699008942, 0.1673406958580017, 0.02542264759540558, 0.11588169634342194, 0.020309822633862495, -0.033169981092214584, -0.09540940821170807, -0.032867271453142166, -0.11349651217460632, -0.06545789539813995, 0.09202520549297333, -0.10331526398658752, -0.14911893010139465, -0.21694618463516235, -0.07582905888557434, 0.07532472163438797, -0.024358125403523445, 0.001369495876133442, 0.004012430086731911, 0.05797974765300751, -0.0034168376587331295, 0.013803727924823761, -0.009628994390368462, 0.033239834010601044, 0.10336929559707642, -0.13397638499736786, -0.05831203609704971, -0.09540057927370071, 0.049765393137931824, 0.08733102679252625, -1.0094671409888178e-07, 0.02818390354514122, 0.015270045958459377, -0.07886935770511627, -0.005614855792373419, -0.019351838156580925, -0.058483585715293884, -0.1289195865392685, -0.05017590522766113, 0.06098245456814766, 0.09204327315092087, 0.07417017966508865, 0.137783020734787, -0.11077709496021271, -0.046333666890859604, 0.03419871628284454, -0.04976904019713402, -0.07127629220485687, 0.08860006928443909, -0.017809633165597916, 0.1715126782655716, -0.08593986928462982, -0.03647996112704277, 0.026991112157702446, 0.014118747785687447, 0.01770235225558281, -0.13193437457084656, 0.045033831149339676, 0.032116856426000595, 0.05592215806245804, -0.035914331674575806, 0.06743074953556061, 0.06871387362480164, 0.0016999822109937668, 0.06404383480548859, 0.011114989407360554, -0.10031726956367493, -0.02170521393418312, 0.05786988139152527, 0.0873686671257019, 0.1145438402891159, 0.00800499226897955, 0.04322262853384018, 0.0028822124004364014, 0.06664445996284485, -0.16171029210090637, -0.12755244970321655, 0.021193047985434532, 0.005979726556688547, 0.018228575587272644, 0.07399208843708038, -0.0895453467965126, -0.016457954421639442, -0.05493646115064621, -0.04030569642782211, 0.08047656714916229, -0.004813181236386299, -0.11189907789230347, 0.006689428351819515, -0.12145612388849258, -0.12917771935462952, -0.01521895918995142, -0.06301862001419067, 0.10476143658161163, -0.01937326043844223], "changes": {"1wk": 58.22784380354279}}, {"text": "Glucotrack to Present at TechBio Showcase\u2122 2025 Glucotrack, Inc. Wed, Jan 8, 2025, 12:05 AM 4 min read In This Article: GCTK -10.94% Glucotrack, Inc. Presentation to feature an update on the Company\u2019s novel continuous blood glucose monitor for patients with diabetes RUTHERFORD, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (\u201cGlucotrack\u201d or the \u201cCompany\u201d), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it is presenting at TechBio Showcase, part of Biotech Showcase\u2122 2025. Paul V. Goode, President and Chief Executive Officer, will give a corporate update on the Company\u2019s Continuous Blood Glucose Monitor (CBGM). Date: Tuesday, January 14 Time: 9:30am PT Track: Yosemite C (Ballroom Level) TechBio Showcase, as part of Biotech Showcase, is produced by Demy-Colton and EBD Group, and is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters broad geographical investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks. Register now to meet one-to-one: biotechshowcase.com. For more information about Glucotrack\u2019s CBGM, visit glucotrack.com . Information on the Company\u2019s website does not constitute a part of and is not incorporated by reference into this press release. About TechBio SHOWCASE TechBio Showcase is part of Biotech Showcase, which is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 17th year, Biotech Showcase is a well-established, highly respected conference featuring multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry. About\u00a0Glucotrack, Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Story Continues Glucotrack\u2019s CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. For more information, please visit http://www.glucotrack.com . Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as \u201cbelieve\u201d, \u201cexpect\u201d, \u201cplan\u201d and \u201cwill\u201d are intended to identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, management. These statements relate only to events as of the date on which the statements are made, and Glucotrack undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. All of the forward-looking statements made in this press release are qualified by these cautionary statements, and there can be no assurance that the actual results anticipated by Glucotrack will be realized or, even if substantially realized, that they will have the expected consequences to or effects on us or our business or operations. Readers are cautioned that certain important factors may affect Glucotrack\u2019s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect Glucotrack\u2019s results include, but are not limited to, the ability of Glucotrack to raise additional capital to finance its operations (whether through public or private equity offerings, debt financings, strategic collaborations or otherwise); risks relating to the receipt (and timing) of regulatory approvals (including U.S. Food and Drug Administration approval); risks relating to enrollment of patients in, and the conduct of, clinical trials; risks relating to Glucotrack\u2019s future distribution agreements; risks relating to its ability to hire and retain qualified personnel, including sales and distribution personnel; and the additional risk factors described in Glucotrack\u2019s filings with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d), including its Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the SEC on March 28, 2024. Contacts: Investor Relations: investors@glucotrack.com Lisa Wilson In-Site Communications T: 917-543-9932 E: lwilson@insitecony.com Media: GlucotrackPR@icrinc.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GCTK", "date": "2025-01-07T21:05:00+00:00", "sentiment": {"score": 0.03759819362312555, "confidence": 0.05047493427991867, "probabilities": {"positive": 0.05047493427991867, "negative": 0.012876740656793118, "neutral": 0.9366483092308044}}, "embedding": [-0.15937179327011108, -0.025667037814855576, -0.05028409883379936, -0.012950917705893517, 0.047332048416137695, -0.044739730656147, -0.03878827393054962, 0.12193223834037781, 0.04681377485394478, -0.0587722547352314, -0.1522131860256195, -0.06887903809547424, -0.05049855262041092, 0.06684448570013046, -0.13076850771903992, -0.10946337133646011, 0.09895187616348267, -0.017243308946490288, -0.050456710159778595, -0.024312876164913177, 0.03399694710969925, 0.05284099280834198, 0.11781027913093567, 0.08776136487722397, -0.03380618244409561, -0.022119836881756783, -0.02934538759291172, -0.07226227223873138, -0.16706252098083496, -0.02266469970345497, -0.055984221398830414, 0.13268166780471802, 0.07282856106758118, 0.005353577435016632, 0.006354932673275471, 0.09476624429225922, -0.08514130115509033, -0.017983436584472656, -0.06868895888328552, -0.16082289814949036, -0.002961190650239587, -0.156879723072052, -0.02398361638188362, 0.13815061748027802, 0.04830978810787201, -0.08452382683753967, -0.04017966240644455, -0.04795851558446884, 0.0368359200656414, 0.08348603546619415, -0.09987634420394897, -0.22101867198944092, 0.03281007334589958, 0.0162475798279047, 0.09296435862779617, 0.09602817893028259, -0.18112021684646606, -0.13820840418338776, 0.02625320851802826, -0.04459795355796814, 0.015032869763672352, -0.04186191409826279, -0.06319375336170197, 0.017686424776911736, 0.13056430220603943, -0.05840892344713211, 0.02511761710047722, 0.13614843785762787, 0.041264936327934265, -0.07472985982894897, 0.06606344878673553, -0.06552651524543762, -0.010209981352090836, 0.14895012974739075, -0.029162954539060593, 0.20244014263153076, 0.004229128360748291, 0.06808307021856308, 0.12149354070425034, -0.05843085050582886, 0.18745315074920654, 0.06038086861371994, 0.15742957592010498, 0.03698080778121948, -0.09500639140605927, -0.039209309965372086, 0.06281116604804993, 0.1416623443365097, -0.10517781972885132, -0.08005982637405396, -0.013890635222196579, 0.0073866089805960655, -0.04000686854124069, -0.0159748587757349, -0.09194223582744598, -0.0806226134300232, -0.10228137671947479, -0.07585654407739639, 0.15011495351791382, 0.07413192093372345, -0.030489854514598846, 0.015153702348470688, 0.08166581392288208, 0.060832977294921875, -0.16801807284355164, -0.18594513833522797, 0.012139607220888138, 0.15956372022628784, 0.18264463543891907, 0.05637767165899277, -0.08951609581708908, 0.1653519719839096, -0.03153685852885246, -0.06402242183685303, -0.09452612698078156, 0.20297729969024658, -0.06325331330299377, 0.06627646833658218, 0.17587728798389435, 0.014110265299677849, 0.06471829861402512, 0.04590537026524544, 0.027367305010557175, -0.1514456868171692, 0.012702448293566704, 0.028427651152014732, -0.01236901618540287, 8.964585874967638e-33, 0.05378267914056778, -0.06333905458450317, 0.0665162056684494, 0.08250601589679718, 0.03637336939573288, 0.048858724534511566, -0.02361884154379368, -0.03622930496931076, -0.02801669016480446, -0.05913372337818146, -0.07433666288852692, 0.11256364732980728, -0.0714040994644165, 0.22004206478595734, -0.10871189832687378, -0.11587114632129669, -0.11146384477615356, -0.017940616235136986, 0.012849917635321617, 0.019054748117923737, -0.046138472855091095, -0.014125090092420578, -0.02850637212395668, 0.07138232886791229, -0.04135506600141525, 0.10002119839191437, -0.07663661241531372, 0.04053003713488579, 0.05598469823598862, 0.07855302095413208, -0.14099088311195374, 0.055486880242824554, 0.018822357058525085, -0.08648493885993958, 0.025089753791689873, -0.08030298352241516, 0.0020730746909976006, -0.2539620101451874, 0.09867669641971588, 0.0929516926407814, -0.07289357483386993, 0.023950371891260147, -0.13066375255584717, -0.11957937479019165, 0.07756732404232025, 0.1174028217792511, 0.06926663964986801, -0.0009740041568875313, 0.0472174733877182, 0.0831039696931839, -0.01840122602880001, 0.07091501355171204, 0.027603309601545334, -0.07884041965007782, 0.052405670285224915, 0.007496572099626064, -0.07037071883678436, -0.08912469446659088, 0.11193922162055969, 0.06189684569835663, -0.00951819121837616, 0.2988431453704834, -0.06783735752105713, 0.030867232009768486, -0.16433311998844147, 0.15679165720939636, -0.08200982958078384, 0.0018125372007489204, -0.022069361060857773, 0.1471303105354309, -0.07057534903287888, -0.00817792396992445, -0.011385355144739151, -0.07240338623523712, -0.016865063458681107, -4.205573350191116e-05, -0.04278597608208656, 0.10656954348087311, -0.0871066078543663, 0.0018810201436281204, 0.04682358726859093, -0.00445819366723299, -0.05155216157436371, -0.02769734151661396, -0.09695279598236084, 0.026212548837065697, -0.00587724894285202, -0.015951158478856087, -0.17801836133003235, -0.06707645952701569, -0.07461577653884888, 0.09330005198717117, -0.005222970619797707, 0.19769223034381866, 0.028120603412389755, -1.1809238122919418e-32, 0.1278536319732666, -0.08455924689769745, 0.0022116084583103657, -0.036581315100193024, 0.11530540883541107, 0.012179396115243435, 0.03790534660220146, -0.18233758211135864, 0.03578323870897293, 0.013665707781910896, 0.04778793454170227, 0.12560543417930603, -0.01776326447725296, 0.020792128518223763, -0.021182365715503693, 0.058124929666519165, -0.08461278676986694, -0.03171157091856003, -0.1662784367799759, 0.06513862311840057, 0.0017929412424564362, 0.20480258762836456, -0.153110072016716, -0.14232350885868073, 0.04611346870660782, 0.0331113375723362, 0.08180498331785202, 0.10769205540418625, 0.08523941785097122, -0.0862215906381607, -0.06797896325588226, -0.02114148810505867, -0.25363287329673767, 0.0015654871240258217, 0.06153047829866409, -0.003983170725405216, 0.05882737785577774, -0.1716800034046173, 0.01667770929634571, -0.07753290235996246, 0.09717381000518799, 0.06785643100738525, -0.10907687991857529, 0.0363207645714283, 0.058604076504707336, 0.0031671742908656597, -0.049512214958667755, -0.013646392151713371, 0.07911397516727448, -0.0318782813847065, -0.04549901932477951, 0.03866710513830185, -0.03818702697753906, -0.1279582381248474, -0.07851558178663254, -0.02207806706428528, 0.06413143128156662, -0.04331415146589279, -0.09525546431541443, 0.0073793441988527775, -0.06719313561916351, -0.053908172994852066, 0.009264654479920864, 0.035897593945264816, 0.13055172562599182, 0.05068516731262207, 0.19285310804843903, 0.0872703492641449, -0.0037349313497543335, 0.10192574560642242, 0.007097302004694939, -0.04168621450662613, -0.011076532304286957, -0.13747012615203857, -0.021351460367441177, 0.11837584525346756, -0.040825601667165756, -0.0303198229521513, -0.12094052135944366, -0.06395399570465088, 0.04107724130153656, 0.03695349022746086, 0.07917571812868118, -0.027218008413910866, 0.10658953338861465, 0.0699853003025055, -0.09372002631425858, 0.12082614004611969, -0.06130564957857132, 0.08007824420928955, -0.08692630380392075, -0.08412861078977585, -0.0843537300825119, 0.117263063788414, 0.08033653348684311, -1.0107391545943756e-07, 0.07794063538312912, 0.0048436131328344345, -0.04146973788738251, -0.10386192798614502, 0.060246165841817856, -0.0598856545984745, -0.06065142899751663, 0.012041956186294556, 0.13095435500144958, 0.09799790382385254, -0.01144430786371231, 0.15518511831760406, -0.17167192697525024, 0.12508326768875122, 0.02869066782295704, -0.011996814049780369, -0.15880417823791504, 0.016542751342058182, -0.09274508059024811, 0.03044155240058899, -0.06292584538459778, -0.06573541462421417, 0.05871330946683884, -0.02470508962869644, -0.07378998398780823, -0.11843091249465942, 0.040615424513816833, 0.015377373434603214, -0.002061278559267521, -0.07020197808742523, -0.020701631903648376, 0.0551627092063427, -0.026789233088493347, 0.04813145101070404, 0.0001237187534570694, -0.07824261486530304, -0.03904831409454346, 0.045978792011737823, 0.03231431916356087, 0.11837389320135117, -0.07655490934848785, -0.07970639318227768, 0.03209089860320091, 0.04113978520035744, -0.10024239122867584, -0.10799042880535126, -0.04973461478948593, -0.04106493666768074, -0.05766681581735611, 0.03828825056552887, -0.13916510343551636, -0.0816720724105835, -0.03306426852941513, -0.010253772139549255, 0.04843301326036453, 0.11200684309005737, -0.07025928795337677, -0.03753075748682022, -0.013106239028275013, -0.031120341271162033, 0.06707079708576202, -0.10611879825592041, 0.07914302498102188, 0.01883567124605179], "changes": {"1wk": -21.290318313423843}}, {"text": "GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR GlucoTrack, Inc. Tue, Dec 3, 2024, 4:30 PM 4 min read In This Article: GCTK -10.94% GlucoTrack, Inc. Feasibility study underway for the Company\u2019s novel continuous blood glucose monitor in patients with diabetes, with data expected within 6-8 weeks Rutherford, NJ, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (\u201cGlucotrack\u201d or the \u201cCompany\u201d), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, has announced the commencement of patient enrollment for its short-term human clinical study. The study will focus on the Company\u2019s continuous blood glucose monitor (\u201cCBGM\u201d) and will include participants with both type 1 and type 2 diabetes. Data from the study is expected to be available within 6-8 weeks. Unlike traditional continuous glucose monitors that measure glucose levels in interstitial fluid, Glucotrack\u2019s CBGM measures glucose directly from blood, aiming to provide real-time readings without the lag time typically associated with interstitial glucose measurements. The CBGM is a long-term implantable device with no on-body external component, designed for three years of continuous, accurate blood glucose monitoring, offering a more convenient and less intrusive glucose monitoring solution. The prospective, single arm study is a short-term in-hospital study in which the CBGM sensor will be placed intravascularly for a period of four days. Study participants, who have been diagnosed with diabetes mellitus requiring glucose monitoring and intensive insulin therapy, will participate in several fixed meal and glucose challenges during the study period. The study is being conducted under Principal Investigator Dr. Alexandre Abizaid, MD, PhD. Dr. Abizaid is the Director of Interventional Cardiology at Instituto do Cora\u00e7\u00e3o in S\u00e3o Paulo, Brazil, and a Visiting Professor of Medicine at Columbia University Medical Center in New York City. He is a key faculty member of the Cardiovascular Research Foundation in New York and a world-renowned interventional cardiologist who has conducted numerous first in human clinical studies in the cardiology field. The study will be conducted at Instituto do Cora\u00e7\u00e3o (InCor) of the Hospital das Cl\u00ednicas of Faculdade de Medicina da Universidade de S\u00e3o Paulo, which is widely considered the best cardiology hospital in Brazil and Latin America, according to Newsweek . \u201cFollowing the success of our preclinical program, we are pleased to reach this key milestone in the development of our novel CBGM,\u201d said Paul V. Goode, PhD, President & Chief Executive Officer of Glucotrack. \u201cWe believe this groundbreaking early feasibility study will demonstrate the potential for our real-time continuous blood glucose monitor to offer a truly differentiated and less burdensome approach to glucose monitoring for people with diabetes.\u201d Story Continues For more information about Glucotrack\u2019s CBGM, visit glucotrack.com . Information on the Company\u2019s website does not constitute a part of and is not incorporated by reference into this press release. # # # About\u00a0Glucotrack, Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack\u2019s CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. For more information, please visit http://www.glucotrack.com . Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as \u201cbelieve\u201d, \u201cexpect\u201d, \u201cplan\u201d and \u201cwill\u201d are intended to identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, management. These statements relate only to events as of the date on which the statements are made, and Glucotrack undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. All of the forward-looking statements made in this press release are qualified by these cautionary statements, and there can be no assurance that the actual results anticipated by Glucotrack will be realized or, even if substantially realized, that they will have the expected consequences to or effects on us or our business or operations. Readers are cautioned that certain important factors may affect Glucotrack\u2019s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect Glucotrack\u2019s results include, but are not limited to, the ability of Glucotrack to raise additional capital to finance its operations (whether through public or private equity offerings, debt financings, strategic collaborations or otherwise); risks relating to the receipt (and timing) of regulatory approvals (including U.S. Food and Drug Administration approval); risks relating to enrollment of patients in, and the conduct of, clinical trials; risks relating to Glucotrack\u2019s future distribution agreements; risks relating to its ability to hire and retain qualified personnel, including sales and distribution personnel; and the additional risk factors described in Glucotrack\u2019s filings with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d), including its Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the SEC on March 28, 2024. Contacts: Investor Relations: investors@glucotrack.com Lisa Wilson In-Site Communications T: 917-543-9932 E: lwilson@insitecony.com Media: GlucotrackPR@icrinc.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GCTK", "date": "2024-12-03T13:30:00+00:00", "sentiment": {"score": 0.06262600980699062, "confidence": 0.074276864528656, "probabilities": {"positive": 0.074276864528656, "negative": 0.011650854721665382, "neutral": 0.9140723347663879}}, "embedding": [-0.1359100192785263, 0.01790487766265869, -0.1481260061264038, 0.05207355320453644, -0.04840359091758728, -0.11255310475826263, -0.05309485271573067, 0.14846087992191315, 0.05710684880614281, -0.09583553671836853, -0.13261815905570984, -0.010902008041739464, -0.1064620316028595, 0.05197165906429291, -0.1553391069173813, -0.13852864503860474, 0.1198144257068634, 0.004441887140274048, -0.027739087119698524, 0.0800914466381073, 0.01402585580945015, -0.02638796530663967, 0.11972535401582718, 0.09569375962018967, -0.09294817596673965, -0.09912287443876266, -0.030846543610095978, -0.14369894564151764, -0.11930091679096222, 0.02794784866273403, -0.09182102233171463, 0.07225793600082397, 0.10128028690814972, 0.11719579249620438, -0.06951643526554108, 0.15886014699935913, -0.05566544830799103, -0.009168041869997978, -0.1503811776638031, -0.16461427509784698, 0.01865650713443756, -0.09231815487146378, -0.006466621067374945, 0.09510189294815063, 0.08053527027368546, -0.017301248386502266, -0.11063852906227112, 0.025995710864663124, -0.10035228729248047, 0.136101633310318, -0.04982854798436165, 0.0018444620072841644, 0.01632695086300373, 0.0724947601556778, 0.09649278968572617, 0.10184591263532639, -0.2217624932527542, -0.08993373811244965, 0.05590098351240158, 0.03860689699649811, -0.10911344736814499, 0.07590191811323166, -0.09801818430423737, -0.045537080615758896, 0.028765685856342316, -0.04713186249136925, 0.018223319202661514, -0.04626384377479553, 0.05212004855275154, 0.013761384412646294, 0.014033065177500248, -0.003691416932269931, -0.05334562808275223, 0.018554437905550003, -0.037515636533498764, 0.07387387752532959, -0.0754871666431427, 0.11346667259931564, 0.11741448938846588, -0.04099370911717415, 0.1919914036989212, 0.05492941290140152, 0.18965774774551392, 0.09758530557155609, -0.05446271225810051, -0.05113135278224945, 0.08794136345386505, 0.22608375549316406, -0.21406742930412292, -0.09744952619075775, 0.17253389954566956, 0.08653351664543152, -0.16166846454143524, 0.07920584082603455, -0.062420692294836044, -0.07158572971820831, 0.02976403385400772, -0.045968737453222275, 0.06925760209560394, 0.03051117993891239, 0.013825845904648304, -0.05934920907020569, 0.10985851287841797, 0.10887265205383301, -0.10668501257896423, -0.12297175079584122, 0.05130382627248764, 0.05088640749454498, 0.12373504042625427, 0.0505182221531868, 0.02417152374982834, 0.11670409888029099, -0.03885599970817566, -0.054242052137851715, -0.09768359363079071, 0.15450353920459747, -0.09907367825508118, 0.031593289226293564, 0.19965620338916779, 0.16714318096637726, 0.013317326083779335, -0.0314967967569828, 0.023649215698242188, -0.1881248950958252, 0.10291014611721039, 0.1134166270494461, 0.17741431295871735, 1.2912391082024163e-32, 0.00333631644025445, -0.18050241470336914, 0.05122728273272514, -0.08896580338478088, -0.0785222128033638, 0.09672634303569794, -0.0375915989279747, 0.06797084957361221, 0.15472078323364258, -0.00050962227396667, -0.06865712255239487, 0.0995408445596695, -0.12913104891777039, 0.14631003141403198, -0.10959171503782272, -0.019025661051273346, -0.016867879778146744, -0.031231604516506195, 0.044085267931222916, 0.07322006672620773, 0.06182320788502693, -0.04618676006793976, -0.023484472185373306, 0.06815766543149948, 0.006143511738628149, 0.08340416848659515, -0.08098645508289337, 0.05605171248316765, -0.013059303164482117, 0.07473278790712357, -0.05725472420454025, 0.058317266404628754, -0.014428499154746532, -0.04082111269235611, -0.08419232070446014, -0.06832265108823776, -0.019153930246829987, -0.07800514250993729, -0.02060864120721817, 0.009722469374537468, -0.04883895069360733, 0.051335759460926056, 0.04557551443576813, -0.14651645720005035, 0.04059232771396637, 0.010992554947733879, 0.04856236279010773, 0.04477209597826004, -0.00924762338399887, 0.10818789899349213, -0.035087596625089645, -0.0038476670160889626, -0.09860323369503021, -0.05467233806848526, -0.010991282761096954, 0.12622126936912537, 0.002322448417544365, -0.05703809857368469, 0.04862143099308014, 0.02730622887611389, -0.029242219403386116, 0.18617033958435059, -0.0019071070710197091, -0.02783864550292492, -0.054398246109485626, 0.0747964084148407, -0.2319171279668808, -0.05969928577542305, -0.04942256957292557, 0.011196183040738106, -0.029404237866401672, -0.02020471915602684, -0.0001902356743812561, 0.010542900301516056, -0.030430058017373085, -0.04579287767410278, 0.07059423625469208, 0.14406128227710724, -0.11133931577205658, -0.05096745863556862, 0.141453817486763, 0.04162469133734703, 0.051621515303850174, -0.060133516788482666, -0.1297731101512909, 0.05723939836025238, -0.012786075472831726, -0.061671219766139984, -0.2343822568655014, -0.08475632965564728, -0.13769373297691345, 0.1823054552078247, -0.02336142398416996, 0.05171360820531845, 0.03919272869825363, -1.4653317317375172e-32, 0.12198507785797119, -0.09195508062839508, 0.06019763648509979, -0.04408857971429825, 0.2142234742641449, 0.002918568439781666, 0.133818119764328, -0.16357479989528656, 0.1015806645154953, -0.04810883477330208, 0.03588220477104187, 0.11295343190431595, 0.032023344188928604, 0.14587780833244324, -0.0030323672108352184, 0.12755833566188812, -0.2286035120487213, -0.02685800939798355, -0.12826086580753326, 0.08861234039068222, -0.021541476249694824, 0.15557719767093658, -0.0829966813325882, -0.10762894153594971, 0.029594747349619865, -0.023694919422268867, 0.08755398541688919, 0.09248291701078415, 0.01998615823686123, -0.11960363388061523, -0.02818467654287815, -0.048980049788951874, -0.16628089547157288, -0.020605888217687607, 0.0981353372335434, -0.13314230740070343, 0.03582150489091873, -0.03624901920557022, -0.11104384064674377, -0.006948674097657204, 0.10588466376066208, 0.17951494455337524, -0.06998547166585922, -0.12224835157394409, 0.15164819359779358, 0.074524886906147, 0.06398426741361618, -0.07501132786273956, -0.06492584198713303, -0.0357494130730629, -0.050679780542850494, 0.06839857250452042, -0.07429851591587067, -0.02262585237622261, -0.03657280653715134, 0.006939300335943699, 0.05976250767707825, -0.13198578357696533, -0.07630933076143265, -0.0059333122335374355, -0.028744429349899292, -0.11561515927314758, 0.02421349100768566, 0.043561287224292755, 0.1682460904121399, 0.1135069876909256, 0.2129458338022232, -0.016812574118375778, 0.13882626593112946, 0.16158989071846008, -0.028459012508392334, -0.09841639548540115, -0.020232941955327988, -0.07972042262554169, 0.06546544283628464, 0.057191748172044754, -0.09492771327495575, -0.06516849994659424, -0.10091738402843475, -0.18348228931427002, 0.06308114528656006, -0.02082594484090805, -0.008408935740590096, -0.011921335011720657, 0.02729681506752968, -0.06587551534175873, -0.03675395995378494, 0.0005849767476320267, 0.06755373626947403, 0.09731313586235046, -0.1073666661977768, 0.024735288694500923, -0.09204205870628357, -0.004581116139888763, 0.09449680894613266, -1.004464706966246e-07, 0.016698317602276802, 0.005998918786644936, -0.10479782521724701, 0.048334598541259766, 0.046567123383283615, -0.12231546640396118, -0.0670836791396141, -0.05314753204584122, 0.02244717627763748, 0.003965684678405523, 0.046311669051647186, 0.15390728414058685, -0.07016409933567047, -0.0587301068007946, -0.020933836698532104, -0.024143900722265244, -0.007494265213608742, -0.024195842444896698, -0.04596463963389397, 0.16504529118537903, -0.054527491331100464, -0.06907260417938232, -0.084406778216362, -0.057198382914066315, -0.027274668216705322, -0.06388556957244873, 0.07123780250549316, 0.0526462197303772, 0.011164698749780655, -0.027066584676504135, 0.04390442371368408, 0.10427068918943405, 0.07397515326738358, 0.04356466233730316, -0.031953711062669754, -0.07247256487607956, -0.06543286144733429, 0.05938221514225006, -0.023943345993757248, 0.08076739311218262, -0.0028905291110277176, -0.053491219878196716, -0.006500439718365669, -0.005597822368144989, -0.04569673538208008, -0.20411385595798492, 0.03200320154428482, -0.05208810791373253, 0.001686994917690754, 0.15511421859264374, -0.13693754374980927, -0.02012360282242298, -0.11296071112155914, 0.06271945685148239, 0.1979674994945526, 0.007384977303445339, -0.06121654063463211, 0.009038098156452179, -0.060074105858802795, -0.07882343232631683, 0.02353835292160511, -0.03307795152068138, -0.0012221671640872955, -0.02561372146010399], "changes": {"1wk": 11.019742372639428, "1mo": 53.37171624227602}}, {"text": "Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering GlucoTrack, Inc. Wed, Nov 13, 2024, 5:00 PM 5 min read In This Article: GCTK -10.94% GlucoTrack, Inc. Rutherford, NJ., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the launch of a \u201cbest efforts\u201d public offering of approximately 7,195,000 shares of common stock (or pre-funded warrants in lieu thereof) with each share of common stock (or pre-funded warrant) accompanied by (i) a series A common warrant to purchase one (1) common share at an exercise price of $1.81 per share and (ii) a series B common warrant to purchase one (1) common share at an exercise price of $1.81 per share. The combined offering price of each share of common stock together with the accompanying series A and series B common warrants is $1.39, and the combined offering price of each pre-funded warrant together with the accompanying series A and series B common warrants is $1.389. The gross proceeds of the public offering are expected to be approximately $10 million before deducting placement agent fees and offering expenses. The closing of the public offering is expected to occur on or about November 14, 2024, subject to the satisfaction of customary closing conditions. Dawson James Securities, Inc. is acting as the sole placement agent for the public offering. This public offering is being made by the Company pursuant to a registration statement on Form S-1 (File No. 333-282158), which was declared effective by the United States Securities and Exchange Commission (\u201cSEC\u201d) on November 12, 2024. The securities may only be offered by means of a prospectus. Copies of the prospectus may be obtained, when available, at the SEC\u2019s website at www.sec.gov or from Dawson James Securities, Inc. Attention: Prospectus Department, 101 North Federal Highway, Suite 600, Boca Raton, FL 33432, investmentbanking@dawsonjames.com or toll free at 866.928.0928. In a concurrent private placement, the Company has reached an agreement to convert approximately $4.0 million in outstanding secured convertible notes originally issued in July 2024 into equity on substantially the same terms as the public offering. The closing of the private offering is expected to take place concurrently with the closing of the public offering on November 14, 2024, subject to satisfaction of customary closing conditions. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. About Glucotrack, Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Story Continues Glucotrack\u2019s CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 2+ years, no on-body wearable component and with minimal calibration. For more information, please visit http://www.glucotrack.com Forward-Looking Statements This press release may contain statements that constitute \u201cforward-looking statements\u201d within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are statements other than historical facts and may include statements that address future operating, financial or business performance or Glucotrack\u2019s strategies or expectations and statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering, the anticipated use of proceeds therefrom, the completion of the concurrent private placement, and the exercise of the series A warrants and series B warrants or otherwise prior to their expiration. In some cases, you can identify these statements by forward-looking words such as \u201cmay\u201d, \u201cmight\u201d, \u201cwill\u201d, \u201cshould\u201d, \u201cexpects\u201d, \u201cplans\u201d, \u201canticipates\u201d, \u201cbelieves\u201d, \u201cestimates\u201d, \u201cpredicts\u201d, \u201cprojects\u201d, \u201cpotential\u201d, \u201coutlook\u201d or \u201ccontinue\u201d, or the negative of these terms or other comparable terminology. Forward-looking statements are based on management\u2019s current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks and uncertainties include, but are not limited to, market and other conditions, the ability of Glucotrack to raise additional capital to finance its operations (whether through public or private equity offerings, debt financings, strategic collaborations or otherwise); risks relating to the receipt (and timing) of regulatory approvals (including U.S. Food and Drug Administration approval); risks relating to enrollment of patients in, and the conduct of, clinical trials; risks relating to Glucotrack\u2019s future distribution agreements; and risks relating to its ability to hire and retain qualified personnel, including sales and distribution personnel. These risks and uncertainties also include, but are not limited to, those described under the caption \u201cRisk Factors\u201d in Glucotrack\u2019s Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the SEC on March 28, 2024, and in Glucotrack\u2019s other filings with the SEC, which are available free of charge on the SEC\u2019s website at: www.sec.gov . Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. All forward-looking statements and all subsequent written and oral forward-looking statements attributable to Glucotrack or to persons acting on behalf of Glucotrack are expressly qualified in their entirety by reference to these risks and uncertainties. You should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and Glucotrack does not undertake any obligation to update them in light of new information, future developments or otherwise, except as may be required under applicable law. Investor Relations: investors@glucotrack.com Media: GlucotrackPR@icrinc.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GCTK", "date": "2024-11-13T14:00:00+00:00", "sentiment": {"score": 0.012502774596214294, "confidence": 0.0299170333892107, "probabilities": {"positive": 0.0299170333892107, "negative": 0.017414258792996407, "neutral": 0.9526687264442444}}, "embedding": [-0.13132435083389282, -0.06680471450090408, -0.05470085144042969, -0.02633127011358738, -0.08700525760650635, -0.018797101452946663, -0.009773273020982742, 0.11516324430704117, 0.16026675701141357, 0.05255807191133499, 0.04817505180835724, 0.03806104138493538, 0.01886892132461071, -0.05998663231730461, -0.04064248502254486, -0.08150194585323334, 0.04159314185380936, 0.037044450640678406, -0.13604606688022614, 0.16330721974372864, -0.017928950488567352, -0.06375225633382797, -0.023758724331855774, -0.025374626740813255, 0.01611107774078846, -0.11100146174430847, -0.014232375659048557, -0.057582877576351166, -0.11582398414611816, -0.07233926653862, -0.004311621654778719, 0.010174525901675224, 0.030454600229859352, 0.021664492785930634, 0.08519585430622101, -0.015485147014260292, -0.1266193687915802, -0.04016495496034622, 0.02957344427704811, -0.03856527805328369, -0.03300775587558746, -0.019824516028165817, -0.114583820104599, 0.09451621770858765, -0.02494271844625473, 0.017495445907115936, -0.106590136885643, 0.16185981035232544, 0.07829804718494415, -0.0037995753809809685, -0.06993624567985535, -0.050004057586193085, -0.11852913349866867, -0.01616312563419342, -0.018598515540361404, 0.014329003170132637, -0.27744215726852417, -0.07447036355733871, 0.08643931150436401, 0.06731176376342773, 0.04072381556034088, -0.027820754796266556, -0.04209674894809723, 0.05830336734652519, 0.12579107284545898, 0.025509007275104523, 0.093878835439682, -0.05522448569536209, 0.024652108550071716, -0.03229513764381409, 0.14102812111377716, 0.04514116048812866, -0.08505410701036453, -0.06621348857879639, -0.17601168155670166, 0.22150807082653046, -0.040689803659915924, 0.08957038819789886, 0.08766418695449829, -0.13147488236427307, 0.04873969778418541, 0.014528164640069008, 0.012680452316999435, -0.025738274678587914, -0.03843950480222702, -0.14032037556171417, 0.002754760207608342, 0.1168503388762474, 0.0786093920469284, -0.03190482035279274, 0.13834211230278015, -0.08149127662181854, -0.0468098521232605, -0.04405046999454498, -0.09122386574745178, 0.04620696231722832, -0.06477156281471252, -0.019222639501094818, -0.02008652687072754, 0.10790897905826569, 0.04694071039557457, -0.04291171953082085, 0.07197558879852295, -0.018237140029668808, -0.040836311876773834, -0.05140257254242897, 0.002488730475306511, 0.02307959273457527, 0.02130712755024433, -0.033824823796749115, -0.11523982882499695, 0.07579270750284195, -0.07556276768445969, -0.053903572261333466, -0.15830349922180176, 0.13201400637626648, 0.04819578304886818, 0.006940806284546852, 0.19448235630989075, -0.10942591726779938, 0.14026203751564026, 0.03762827813625336, 0.022683337330818176, -0.09658090025186539, -0.08254144340753555, -0.10299406945705414, -0.06047841161489487, 1.0127700800907828e-32, -0.03471545875072479, -0.011205910705029964, 0.04825741797685623, -0.12535196542739868, -0.060639530420303345, -0.0010069829877465963, 0.025979867205023766, 0.016351375728845596, -0.08423889428377151, 0.08418306708335876, -0.08674819767475128, 0.1014908105134964, -0.05368697643280029, -0.04760660603642464, -0.08567284047603607, 0.010597904212772846, 0.06307269632816315, 0.06131509691476822, 0.08639951050281525, 0.010084066540002823, 0.14433152973651886, 0.015704350546002388, 0.028836332261562347, 0.1268978863954544, -0.0716300904750824, 0.012979620136320591, -0.08035100251436234, -0.07124760001897812, 0.02340560406446457, 0.0452166348695755, -0.03609387204051018, 0.03944810479879379, 0.0713178887963295, 0.05233754962682724, 0.029722753912210464, -0.02954975515604019, -0.016135724261403084, -0.15322262048721313, 0.13712403178215027, -0.009987182915210724, -0.15896157920360565, 0.0586768314242363, -0.046002618968486786, -0.08312635868787766, -0.011486445553600788, -0.010396849364042282, -0.027860695496201515, 0.04558467119932175, 0.06881680339574814, -0.010149121284484863, -0.09909379482269287, 0.03920181840658188, -0.17755413055419922, 0.044229380786418915, -0.056070052087306976, 0.03765406832098961, 0.0571012943983078, -0.03499571233987808, 0.03140978515148163, 0.12341752648353577, -2.7062837034463882e-05, 0.14110082387924194, -0.10202264785766602, -0.0007762797176837921, -0.21155758202075958, 0.08717629313468933, -0.09486635029315948, -0.0018543784972280264, -0.06905774027109146, 0.06784366071224213, 0.005036987364292145, -0.01012348011136055, 0.06023446470499039, -0.10120953619480133, 0.047596052289009094, -0.06790587306022644, 0.08702384680509567, 0.07974350452423096, 0.10002408921718597, 0.031491272151470184, -0.04857342317700386, 0.017498677596449852, 0.0032098363153636456, 0.0773186907172203, -0.09171711653470993, 0.04592619463801384, 0.015354804694652557, 0.0607333704829216, -0.05750294774770737, -0.001643347553908825, 0.01233263686299324, 0.027341600507497787, 0.0014682470355182886, 0.11214053630828857, 0.09933268278837204, -1.0046648996050693e-32, -0.0459933765232563, -0.009178557433187962, 0.07049393653869629, -0.011107902973890305, 0.014167550019919872, 0.037093013525009155, 0.06175693869590759, -0.15120476484298706, 0.04924282431602478, 0.026387501507997513, -0.11789383739233017, 0.073074571788311, 0.0468892902135849, 0.03518522530794144, -0.039995647966861725, 0.010291163809597492, 0.016928747296333313, 0.07095421850681305, 0.015608849003911018, 0.0156375914812088, 0.01738375425338745, 0.20954754948616028, 0.04949360340833664, 0.039703257381916046, 0.11638587713241577, -0.014090092852711678, 0.010246124118566513, 0.14395594596862793, -0.04083406925201416, 0.12225664407014847, -0.0007046055980026722, -0.06675088405609131, -0.09928912669420242, 0.06519715487957001, -0.013366892002522945, -0.08230136334896088, 0.14694803953170776, 0.02582838200032711, -0.007459423504769802, -0.03209265321493149, 0.1176692321896553, -0.04165736213326454, 0.08483122289180756, 0.00034102611243724823, 0.0881689190864563, -0.0356314443051815, 0.06891835480928421, -0.10951319336891174, 0.12158609926700592, -0.015549838542938232, -0.048995573073625565, 0.10358285903930664, -0.05027319863438606, 0.12036947906017303, -0.15681390464305878, 0.10351188480854034, 0.024017443880438805, 0.02827412821352482, -0.04607167840003967, -0.008395647630095482, 0.02345261350274086, 0.07450057566165924, -0.0021957941353321075, -0.021579110994935036, 0.20409023761749268, 0.04163258895277977, -0.00844748504459858, -0.08630291372537613, -0.009680596180260181, -0.04825170338153839, -0.08028686046600342, -0.20129168033599854, 0.07299487292766571, -0.15884718298912048, 0.05649873614311218, 0.1614939272403717, 0.02571950852870941, -0.13162636756896973, -0.051387984305620193, 0.02413902059197426, 0.025880686938762665, 0.10709875822067261, -0.00962111260741949, 0.05363975465297699, -0.017585288733243942, -0.003137548454105854, 0.1033739298582077, 0.05930595099925995, -0.06575799733400345, 0.08180870115756989, -0.1155310720205307, 0.013019280508160591, 0.06748902052640915, -0.02228148654103279, -0.04256537929177284, -9.990023386308167e-08, -0.09017425775527954, 0.07399778068065643, -0.02490641176700592, -0.024468669667840004, 0.23268261551856995, -0.12616278231143951, 0.002193715423345566, -0.013292701914906502, -0.05636180192232132, 0.07314224541187286, 0.12037444114685059, 0.042491938918828964, -0.12392965704202652, -0.025615602731704712, -0.19858193397521973, -0.054892756044864655, -0.15087351202964783, 0.007983529008924961, -0.10232938826084137, 0.04184671491384506, 0.0020061912946403027, 0.026042835786938667, 0.07652788609266281, -0.062436267733573914, -0.08975212275981903, -0.05900106579065323, 0.06303833425045013, 0.030538376420736313, 0.013818081468343735, 0.08782482892274857, -0.046584390103816986, -0.016938498243689537, 0.042852144688367844, 0.01172473281621933, -0.045307353138923645, -0.003303651697933674, -0.05133034661412239, 0.19040650129318237, 0.0668744444847107, 0.05999118834733963, -0.025459440425038338, 0.021714776754379272, 0.05413537845015526, 0.08134479820728302, 0.1408747434616089, -0.07949045300483704, -0.23426005244255066, -0.040266238152980804, 0.08457214385271072, -0.04318426549434662, -0.0016658967360854149, -0.020912421867251396, -0.1253499686717987, 0.04579637199640274, 0.046682894229888916, -0.03320946916937828, -0.022629277780652046, 0.06034602224826813, -0.08530152589082718, -0.0015412569046020508, -0.01150522567331791, -0.3144686222076416, 0.023164700716733932, 0.06070243567228317], "changes": {"1wk": -29.22221764517407, "1mo": -22.499999006589228}}, {"text": "Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt GlucoTrack, Inc. Fri, Nov 15, 2024, 12:30 AM 5 min read In This Article: GCTK -10.94% GlucoTrack, Inc. Rutherford, NJ., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the closing of a \u201cbest efforts\u201d public offering of 2,437,340 shares of common stock and 4,756,900 pre-funded warrants, with each share of common stock and each pre-funded warrant accompanied by (i) a series A common warrant to purchase one (1) share of common stock at an exercise price of $1.81 per share and (ii) a series B common warrant to purchase one (1) share of common stock at an exercise price of $1.81 per share. The combined offering price of each share of common stock together with the accompanying series A and series B common warrants is $1.39, and the combined offering price of each pre-funded warrant together with the accompanying series A and series B common warrants is $1.389. The gross proceeds of the public offering were approximately $10 million before deducting placement agent fees and offering expenses. The closing of the public offering occurred on November 14, 2024 and was made by the Company pursuant to a registration statement on Form S-1 (File No. 333-282158), which was declared effective by the United States Securities and Exchange Commission (\u201cSEC\u201d) on November 12, 2024. Dawson James Securities, Inc. acted as the sole placement agent for the public offering. In connection with the public offering, Glucotrack was represent by Nelson Mullins Riley & Scarborough LLP (Atlanta, Ga and Raleigh, NC), and Dawson James Securities, Inc. was represented by ArentFox Schiff LLP (Washington, D.C.). Concurrent with the closing of the public offering, the Company closed a private placement pursuant to which approximately $4.0 million in outstanding secured convertible notes originally issued in July 2024 were converted into equity on substantially the same terms as the public offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. About Glucotrack, Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Story Continues Glucotrack\u2019s CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. For more information, please visit http://www.glucotrack.com Forward-Looking Statements This press release may contain statements that constitute \u201cforward-looking statements\u201d within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are statements other than historical facts and may include statements that address future operating, financial or business performance, the anticipated use of proceeds from the offering, and the exercise of the series A warrants and series B warrants prior to their expiration. In some cases, you can identify these statements by forward-looking words such as \u201cmay\u201d, \u201cmight\u201d, \u201cwill\u201d, \u201cshould\u201d, \u201cexpects\u201d, \u201cplans\u201d, \u201canticipates\u201d, \u201cbelieves\u201d, \u201cestimates\u201d, \u201cpredicts\u201d, \u201cprojects\u201d, \u201cpotential\u201d, \u201coutlook\u201d or \u201ccontinue\u201d, or the negative of these terms or other comparable terminology. Forward-looking statements are based on management\u2019s current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks and uncertainties include, but are not limited to, market and other conditions, the ability of Glucotrack to raise additional capital to finance its operations (whether through public or private equity offerings, debt financings, strategic collaborations or otherwise); risks relating to the receipt (and timing) of regulatory approvals (including U.S. Food and Drug Administration approval); risks relating to enrollment of patients in, and the conduct of, clinical trials; risks relating to Glucotrack\u2019s future distribution agreements; and risks relating to its ability to hire and retain qualified personnel, including sales and distribution personnel. These risks and uncertainties also include, but are not limited to, those described under the caption \u201cRisk Factors\u201d in Glucotrack\u2019s Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the SEC on March 28, 2024, and in Glucotrack\u2019s other filings with the SEC, which are available free of charge on the SEC\u2019s website at: www.sec.gov . Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. All forward-looking statements and all subsequent written and oral forward-looking statements attributable to Glucotrack or to persons acting on behalf of Glucotrack are expressly qualified in their entirety by reference to these risks and uncertainties. You should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and Glucotrack does not undertake any obligation to update them in light of new information, future developments or otherwise, except as may be required under applicable law. Investor Relations: investors@glucotrack.com Media: GlucotrackPR@icrinc.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GCTK", "date": "2024-11-14T21:30:00+00:00", "sentiment": {"score": 0.006197115406394005, "confidence": 0.02670341730117798, "probabilities": {"positive": 0.02670341730117798, "negative": 0.020506301894783974, "neutral": 0.9527903199195862}}, "embedding": [-0.09050749242305756, -0.023392468690872192, -0.07219208031892776, -0.02828413061797619, -0.09909942746162415, -0.055071644484996796, -0.029899172484874725, 0.17344295978546143, 0.12833955883979797, 0.04492252320051193, 0.042030323296785355, 0.11899814009666443, 0.011995414271950722, -0.07845751941204071, -0.07890836894512177, -0.060327351093292236, 0.04259636253118515, 0.0391070619225502, -0.1780252605676651, 0.1566057950258255, -0.038116320967674255, -0.012191219255328178, 0.0031143110245466232, 0.013750925660133362, 0.008741357363760471, -0.04417247325181961, -0.03564230725169182, -0.06772588938474655, -0.12378227710723877, -0.03578891605138779, -0.019599895924329758, -0.0011967960745096207, 0.06406505405902863, 0.01379996258765459, 0.054539185017347336, 0.042916394770145416, -0.13394795358181, -0.04247990623116493, 0.02288375422358513, -0.09825333952903748, -0.00589666748419404, -0.05214761570096016, -0.08691508322954178, 0.06814336776733398, -0.01686767116189003, 0.022380245849490166, -0.08350464701652527, 0.10489308834075928, 0.05771418660879135, 0.03957419469952583, -0.035395216196775436, -0.06362855434417725, -0.11845099925994873, 0.0061820801347494125, 0.0006383853033185005, 0.023129869252443314, -0.2747591435909271, -0.07773466408252716, 0.04493119195103645, 0.10657757520675659, 0.03668087348341942, -0.028922419995069504, -0.043500207364559174, 0.04094087705016136, 0.12448839843273163, 0.02286546677350998, 0.10127672553062439, -0.09004322439432144, 0.036344364285469055, -0.04445173963904381, 0.1651504933834076, 0.044476136565208435, -0.040860507637262344, -0.04620007053017616, -0.19481110572814941, 0.21293601393699646, -0.06381288915872574, 0.10468490421772003, 0.07667680084705353, -0.13317640125751495, 0.09508776664733887, -0.001072055660188198, 0.04083401709794998, -0.015923628583550453, -0.0829344391822815, -0.10074450820684433, 0.02942531555891037, 0.11516602337360382, 0.08196663856506348, -0.03562091290950775, 0.16372285783290863, -0.07434093952178955, -0.04650133103132248, -0.021934058517217636, -0.11732842773199081, 0.0030636917799711227, -0.08559674024581909, -0.008245982229709625, -0.012570364400744438, 0.0981062650680542, 0.0527886301279068, -0.04464862868189812, 0.08734056353569031, -0.012380454689264297, -0.032250940799713135, -0.06466057896614075, 0.029598917812108994, 0.00923180766403675, 0.039150893688201904, -0.031918104737997055, -0.12896016240119934, 0.09923940896987915, -0.09237059950828552, -0.061858903616666794, -0.1341923475265503, 0.14848637580871582, 0.03158891201019287, 0.024845879524946213, 0.16777828335762024, -0.07097938656806946, 0.1538918912410736, 0.03798734396696091, 0.0029575685039162636, -0.1120588630437851, -0.04396906867623329, -0.09418831020593643, -0.053663089871406555, 9.772812444238856e-33, -0.012142553925514221, -0.042320579290390015, 0.06090619042515755, -0.09755025058984756, -0.03367569297552109, 0.0007600343669764698, 0.027104200795292854, 0.028898119926452637, -0.06492872536182404, 0.06717969477176666, -0.04233240336179733, 0.053936973214149475, -0.07691462337970734, -0.029024403542280197, -0.09074851870536804, 0.02802160754799843, -0.004960477352142334, 0.03944462537765503, 0.09214121848344803, -0.0008160424767993391, 0.1161733940243721, 0.04785164073109627, 0.024725602939724922, 0.14285531640052795, -0.0902291089296341, 0.03362774848937988, -0.09867367148399353, -0.06259151548147202, 0.027887018397450447, 0.028879314661026, -0.016372347250580788, 0.024356123059988022, 0.08001521229743958, 0.07059132307767868, 0.035816699266433716, -0.030480485409498215, -0.02691526710987091, -0.21402713656425476, 0.13865916430950165, -0.004637447185814381, -0.1097770482301712, 0.06201311945915222, -0.060013800859451294, -0.07617373764514923, -0.001279253512620926, 0.019881222397089005, -0.04103388264775276, 0.03657589480280876, 0.057343579828739166, 0.038357943296432495, -0.0801122635602951, 0.033617742359638214, -0.15884283185005188, 0.05505779758095741, -0.08654260635375977, 0.024164734408259392, 0.02879396826028824, -0.04567679762840271, 0.01741856336593628, 0.09320256859064102, -0.022080298513174057, 0.18646672368049622, -0.06933680176734924, -0.012920374982059002, -0.234457328915596, 0.08814387023448944, -0.10596039891242981, 0.004589446354657412, -0.0835801213979721, 0.11444562673568726, 0.0042831432074308395, -0.043645188212394714, 0.003851279616355896, -0.04273989051580429, 0.04119078814983368, -0.0904788002371788, 0.0845441222190857, 0.06934520602226257, 0.1363421529531479, -0.01310200896114111, 0.016618797555565834, 0.04588282108306885, 0.0494421049952507, 0.07085110992193222, -0.16557827591896057, 0.0600985623896122, 0.009908586740493774, 0.03967064246535301, -0.05986882746219635, -0.032246366143226624, -0.06586311012506485, 0.04038814827799797, -0.022982778027653694, 0.1032237708568573, 0.08277827501296997, -1.0621226961312781e-32, -0.05910443514585495, 0.003695058636367321, 0.03808044269680977, 0.014601720497012138, -0.006451745517551899, 0.054375387728214264, 0.06246565282344818, -0.18041473627090454, 0.014412669464945793, 0.041114188730716705, -0.006832277402281761, 0.08531603217124939, 0.0519527792930603, 0.05613664165139198, -0.03189734369516373, 0.025716636329889297, -0.002553393132984638, 0.05631060525774956, 0.029080688953399658, 0.0005673379637300968, 0.02077002078294754, 0.19741274416446686, 0.020809926092624664, 0.028632566332817078, 0.09859167039394379, -0.024832583963871002, -0.016239162534475327, 0.08101242035627365, 0.008248625323176384, 0.04434039816260338, -0.011624936014413834, -0.05621052533388138, -0.0709468200802803, 0.1087559163570404, 0.04995090514421463, -0.09817653894424438, 0.12057876586914062, -0.028415556997060776, -0.008825704455375671, -0.10876438021659851, 0.12586310505867004, -0.019851993769407272, 0.09249180555343628, 0.004151670262217522, 0.06420980393886566, -0.05202701687812805, 0.020161326974630356, -0.08093138039112091, 0.12906414270401, -0.05702965706586838, -0.05992170423269272, 0.09165570139884949, -0.06885088980197906, 0.09261651337146759, -0.13260102272033691, 0.09638014435768127, 0.07678042352199554, -0.017098816111683846, -0.06164789944887161, -0.0339546762406826, -0.015496387146413326, 0.0387783944606781, 0.013324115425348282, -0.06106530502438545, 0.17742696404457092, 0.00963571760803461, 0.03337907791137695, -0.06698297709226608, -0.0444258451461792, -0.0284383837133646, -0.07818702608346939, -0.1950802505016327, 0.0866534635424614, -0.15178781747817993, 0.041964709758758545, 0.1652172952890396, -0.0146908238530159, -0.11642998456954956, -0.08329354226589203, -0.000639685895293951, 0.06210551783442497, 0.09162797033786774, 0.03132394328713417, 0.020512189716100693, -0.005123327486217022, -0.002086387015879154, 0.08982419967651367, 0.03829852491617203, -0.0804637223482132, 0.13530884683132172, -0.12455243617296219, 0.01552853174507618, 0.07310189306735992, 0.007568966597318649, -0.03669431060552597, -1.0022844065815661e-07, -0.08401860296726227, 0.10416673123836517, -0.034445323050022125, -0.019995465874671936, 0.23399823904037476, -0.14330613613128662, -0.00870010070502758, 0.02200355939567089, -0.0548434779047966, 0.07524937391281128, 0.08952949941158295, 0.06670090556144714, -0.17452700436115265, 0.009873404167592525, -0.18396174907684326, -0.055618416517972946, -0.14357465505599976, 0.0032169129699468613, -0.07184518873691559, 0.06896776705980301, -0.014140160754323006, 0.015705052763223648, 0.04085936024785042, -0.11133620142936707, -0.08142159879207611, -0.04905523359775543, 0.08217604458332062, 0.04204536974430084, 0.02374618500471115, 0.08524417877197266, -0.0013347147032618523, -0.023405589163303375, 0.026304777711629868, -0.009767508134245872, -0.06383835524320602, 0.04307447373867035, -0.01565512642264366, 0.15439411997795105, 0.04323551058769226, 0.08955052495002747, -0.02756919153034687, 0.03977350890636444, 0.06359066069126129, 0.07338079810142517, 0.11221657693386078, -0.11259759962558746, -0.20578867197036743, -0.0500829741358757, 0.07212433218955994, -0.03652164340019226, 0.01809396967291832, -0.0040835728868842125, -0.14305469393730164, 0.027265647426247597, 0.05123640596866608, -0.061121948063373566, -0.015392645262181759, 0.05895495042204857, -0.12072320282459259, -0.07166869938373566, -0.028162961825728416, -0.28539788722991943, 0.03593296557664871, 0.07800963521003723], "changes": {"1wk": -18.968872151829647, "1mo": -16.309987125087957}}, {"text": "PREMIUM Top Midday Decliners MT Newswires Wed, Nov 13, 2024, 10:25 PM 1 min read Top Midday Decliners PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Condizioni e Informativa sulla privacy Privacy Dashboard Storie consigliate", "symbol": "GCTK", "date": "2024-11-13T19:25:10+00:00", "sentiment": {"score": 0.04577778745442629, "confidence": 0.06013237312436104, "probabilities": {"positive": 0.06013237312436104, "negative": 0.01435458566993475, "neutral": 0.9255130887031555}}, "embedding": [-0.11403820663690567, -0.02861141972243786, 0.12835624814033508, 0.14656783640384674, 0.1319444626569748, -0.03748275339603424, 0.001317351358011365, 0.05589122697710991, -0.020748255774378777, -0.0064014168456196785, -0.07356429100036621, 0.05897727981209755, 0.013634233735501766, 0.06955964863300323, 0.0759330466389656, -0.09465138614177704, 0.12112616747617722, -0.06890024989843369, 0.04671837389469147, 0.04408100247383118, -0.12032553553581238, -0.04902273789048195, -0.043875619769096375, 0.06285064667463303, 0.13461287319660187, 0.026607191190123558, -0.1244107186794281, 0.07636398077011108, -0.022328684106469154, -0.040852561593055725, -0.07090175151824951, -0.007964534685015678, 0.11415059864521027, -0.019433917477726936, -0.09221965819597244, -0.12210165709257126, 0.038517195731401443, 0.01572759635746479, 0.0117934700101614, 0.0749439150094986, 0.06563219428062439, -0.1968182623386383, -0.11385668069124222, -0.1031263992190361, -0.09597849100828171, -0.10087697952985764, -0.008731148205697536, 0.014936947263777256, -0.015341529622673988, 0.11690948158502579, -0.011733165010809898, 0.010378450155258179, 0.022431964054703712, -0.1299200803041458, -0.02351062372326851, -0.0632680207490921, -0.16369575262069702, -0.1578616499900818, 0.06311396509408951, -0.02518806979060173, -0.07675326615571976, -0.07164501398801804, -0.19671931862831116, 0.002703561680391431, 0.03339683264493942, 0.11224658787250519, -0.0056700375862419605, 0.2707791328430176, -0.04706082493066788, -0.1628132313489914, 0.010270454920828342, 0.10243993252515793, 0.0771220251917839, 0.04909723624587059, 0.05593353882431984, 0.029813319444656372, 0.15975187718868256, -0.14761218428611755, 0.040479131042957306, -0.032811686396598816, 0.03439813107252121, -0.07007937133312225, -0.05402592569589615, -0.05480435863137245, 0.01319784764200449, -0.05058242008090019, 0.11714733392000198, 0.00870883371680975, -0.023137615993618965, -0.23253260552883148, -0.01751459389925003, 0.07711368054151535, -0.06103988736867905, 0.060097839683294296, -0.07367341965436935, 0.013796464540064335, -0.1903873085975647, -0.08705954253673553, -0.16400355100631714, 0.1250048577785492, 0.07099030911922455, -0.006264267954975367, -0.06873192638158798, -0.00670634675770998, -0.036050453782081604, -0.16230064630508423, -0.11576361954212189, 0.18462823331356049, -0.014853459782898426, 0.04113681614398956, -0.014118129387497902, 0.03985046595335007, 0.05985674634575844, -0.21993595361709595, 0.028596563264727592, 0.09996002167463303, -0.09969668090343475, -0.015467685647308826, 0.09833008795976639, 0.05495913326740265, 0.01619294472038746, 0.10304243117570877, -0.1016162633895874, -0.016849523410201073, 0.16792325675487518, 0.06697242707014084, 0.07059744000434875, 2.2607404167337816e-32, 0.06916117668151855, 0.026070786640048027, 0.09749815613031387, -0.07982226461172104, 0.09437134861946106, 0.0067222402431070805, -0.0691925585269928, -0.03186527267098427, 0.005366592202335596, -0.09316906332969666, -0.0477788932621479, 0.15645381808280945, -0.0860862210392952, 0.009964077733457088, -0.14724834263324738, -0.21045437455177307, 0.1776490956544876, 0.028382504358887672, 0.015906671062111855, -0.023847032338380814, -0.04899078235030174, -0.1428745687007904, -0.10137918591499329, -0.007765423972159624, -0.10715396702289581, 0.06440537422895432, 0.023637963458895683, -0.07897421717643738, 0.18873333930969238, 0.12761281430721283, -0.03325086832046509, -0.07017619907855988, -0.018821651116013527, 0.016635488718748093, 0.043400660157203674, 0.12955495715141296, -0.04052457958459854, 0.00036010079202242196, -0.05153055116534233, -0.25375452637672424, -0.056855201721191406, -0.040163516998291016, -0.18490438163280487, 0.06696175038814545, -0.06836182624101639, 0.027684124186635017, 0.1439868062734604, -0.07467447966337204, 0.013655229471623898, -0.032729264348745346, -0.042185887694358826, 0.09365300834178925, -0.21395540237426758, 0.06151508912444115, -0.023776622489094734, 0.08441508561372757, -0.035458557307720184, -0.12980148196220398, 0.11036157608032227, -0.05201634019613266, 0.12990117073059082, 0.062161266803741455, 0.01755102351307869, -0.179443821310997, -0.06649447232484818, 0.021723516285419464, 0.023639023303985596, 0.021416259929537773, -0.1263170689344406, 0.12613877654075623, 0.16796107590198517, -0.004744417499750853, 0.03380071744322777, 0.10391082614660263, -0.017374126240611076, 0.17257334291934967, 0.136879101395607, 0.004664088599383831, 0.23423470556735992, 0.05016679689288139, 0.13424420356750488, -0.024985171854496002, 0.1756572276353836, -0.08007316291332245, 0.1067141741514206, 0.1037498414516449, 0.14351381361484528, -0.13970200717449188, -0.00827569980174303, 0.04986223205924034, -0.15466955304145813, 0.08535018563270569, 0.011810562573373318, 0.14661437273025513, -0.07432806491851807, -2.144641982490849e-32, -0.088020920753479, 0.008970429189503193, -0.07297069579362869, 0.0354301780462265, -0.13502678275108337, -0.039088763296604156, 0.0065947966650128365, 0.1263495832681656, 0.14328908920288086, 0.15850485861301422, 0.024070980027318, -0.012881970033049583, -0.06150471791625023, -0.007972721010446548, 0.07969829440116882, -0.06986510753631592, 0.18454009294509888, -0.036212459206581116, -0.16433395445346832, 0.010189278982579708, -0.04250285401940346, 0.1332077831029892, -0.2111901193857193, 0.04821659252047539, 0.1475856900215149, 0.019888944923877716, 0.09674737602472305, 0.18305255472660065, 0.03005163185298443, -0.043123096227645874, -0.16917215287685394, -0.04451517388224602, -0.08151190727949142, -0.08471456170082092, -0.025185244157910347, 0.06262215971946716, 0.09359769523143768, 0.08594278246164322, -0.08990883082151413, 0.02738855592906475, 0.08209095150232315, -0.028744954615831375, 0.023441487923264503, 0.04030740261077881, 0.023084236308932304, 0.025386882945895195, -0.06511545926332474, -0.02192460559308529, 0.04863641411066055, -0.02429979480803013, -0.046541258692741394, -0.010518301278352737, -0.008865210227668285, 0.22780953347682953, -0.040076300501823425, 0.09643112868070602, -0.024034254252910614, -0.04894519969820976, 0.11089487373828888, -0.011712055653333664, -0.026751970872282982, 0.0971185714006424, -0.2227790504693985, -0.019046487286686897, 0.10310100764036179, -0.04142744466662407, 0.11706781387329102, -0.1800539344549179, -0.06705635786056519, 0.08003608882427216, -0.029024364426732063, -0.08030758053064346, -0.08799386769533157, -0.32590892910957336, -0.021868908777832985, 0.1562231183052063, -0.06985514611005783, 0.25493350625038147, -0.10258238762617111, -0.050522610545158386, 0.08542978763580322, -0.024012064561247826, -0.10597478598356247, -0.11635391414165497, -0.004400684963911772, -0.041961733251810074, 0.1319981813430786, -0.061416301876306534, -0.09222795814275742, 0.013881721533834934, -0.03691555932164192, -0.12066178023815155, -0.1187809407711029, 0.08414079248905182, -0.014129550196230412, -1.0031501318508163e-07, 0.036342885345220566, -0.030616378411650658, -0.09798381477594376, 0.01330553274601698, 0.11864940822124481, 0.06740787625312805, 0.025405488908290863, -0.07672403007745743, 0.0898195207118988, 0.2642795741558075, 0.09559071809053421, -0.12788845598697662, -0.01053121592849493, -0.021978085860610008, 0.03297238051891327, 0.027115149423480034, -0.04341655969619751, -0.10474503040313721, -0.015669170767068863, -0.19443759322166443, 0.13696879148483276, 0.02843889780342579, 0.1787233203649521, -0.13935424387454987, 0.10455017536878586, -0.027209065854549408, 0.0039098067209124565, 0.049565959721803665, -0.005582099314779043, 0.0033843449782580137, -0.12730923295021057, 0.10514647513628006, -0.21452026069164276, -0.21798862516880035, 0.1429622769355774, 0.1820618063211441, -0.09038051962852478, 0.045452017337083817, -0.008706941269338131, 0.030879320576786995, 0.026928383857011795, -0.14327524602413177, -0.0043152328580617905, 0.08284849673509598, 0.06774631142616272, -0.011473557911813259, -0.10120983421802521, -0.09099645912647247, 0.11701100319623947, -0.13309966027736664, -0.0035385231021791697, -0.09596376866102219, 0.27516308426856995, 0.05574651062488556, 0.06784660369157791, 0.03751717507839203, 0.0859532356262207, -0.13157404959201813, -0.1536126583814621, 0.08900315314531326, 0.12016110867261887, -0.1228855773806572, -0.24923008680343628, 0.07661715894937515], "changes": {"1wk": -26.08333100433697, "1mo": -28.30555116615166}}, {"text": "LiveOne and DAX United States Launch Exclusive Partnership Projected to Increase Programmatic Audio Advertising Revenues Liveone, Inc. Tue, Dec 10, 2024, 9:53 PM 4 min read In This Article: LVO -9.66% PODC -0.43% Liveone, Inc. LOS ANGELES, Dec. 10, 2024 (GLOBE NEWSWIRE) -- LiveOne ( NASDAQ: LVO ), an award-winning, creator-first, music, entertainment, and technology platform, announced today an exclusive audio advertising partnership with DAX, a leading digital advertising platform in the United States. Under the terms of the agreement, DAX will serve as LiveOne's exclusive audio advertising sales partner in the U.S. This partnership is expected to significantly enhance LiveOne's audio ad monetization capabilities, with projected improvements of programmatic audio advertising revenues. \"We're excited to partner with DAX to maximize our advertising opportunities and provide the best value in music to consumers,\" said Bill Wittress, SVP of Business Development and Strategic Partnerships for LiveOne . \"I\u2019m thrilled that we're continuing our longstanding exclusive partnership with LiveOne, a pioneer in the streaming music space,\" added Brian Conlan, President of DAX United States . \"This collaboration empowers us to deliver innovative advertising solutions that connect brands with a passionate and engaged audience. With LiveOne's vast user base, we can offer advertising clients huge reach and access to an engaged audience that's eager to connect with brands that align with their lifestyle.\" DAX is a leading digital advertising platform in the United States, helping brands connect with over 108 million listeners through music, podcasts, radio, mobile games, and audio articles. With content from a network of premium publishers, DAX offers advertisers unparalleled access to diverse and engaged audiences. About LiveOne Headquartered in Los Angeles, CA, LiveOne (Nasdaq: LVO ) is an award-winning, creator-first, music, entertainment, and technology platform focused on delivering premium experiences and content worldwide through memberships and live and virtual events. LiveOne's subsidiaries include Slacker, PodcastOne (Nasdaq: PODC ), PPVOne, CPS, LiveXLive, DayOne Music Publishing, Drumify and Splitmind. LiveOne is available on iOS, Android, Roku, Apple TV, Spotify, Samsung, Amazon Fire, Android TV, and through STIRR's OTT applications. For more information, visit liveone.com and follow us on Facebook , Instagram , TikTok , YouTube and Twitter at @liveone . For more investor information, please visit ir.liveone.com . About DAX United States DAX United States is a pioneering digital advertising exchange that helps brands connect with over 108 million U.S. listeners across music, radio, podcasts, mobile games, and audio articles. Founded by Global in 2017, DAX's North American headquarters is located in New York City\u2019s historic Penn District. Story Continues https://dax.global.com/us/ https://www.linkedin.com/company/dax-united-states/ https://www.youtube.com/@DAXUnitedStatesYT Forward-Looking Statements All statements other than statements of historical facts contained in this press release are \u201cforward-looking statements,\u201d which may often, but not always, be identified by the use of such words as \u201cmay,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cwill likely result,\u201d \u201cwould,\u201d \u201cshould,\u201d \u201cestimate,\u201d \u201cplan,\u201d \u201cproject,\u201d \u201cforecast,\u201d \u201cintend,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cbelieve,\u201d \u201cseek,\u201d \u201ccontinue,\u201d \u201ctarget\u201d or the negative of such terms or other similar expressions. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including: LiveOne\u2019s reliance on its largest OEM customer for a substantial percentage of its revenue; LiveOne\u2019s ability to consummate any proposed financing, acquisition, spin-out, special dividend, merger, distribution or transaction, the timing of the consummation of any such proposed event, including the risks that a condition to the consummation of any such event would not be satisfied within the expected timeframe or at all, or that the consummation of any proposed financing, acquisition, spin-out, merger, special dividend, distribution or transaction will not occur or whether any such event will enhance shareholder value; LiveOne\u2019s ability to continue as a going concern; LiveOne\u2019s ability to attract, maintain and increase the number of its users and paid members; LiveOne identifying, acquiring, securing and developing content; LiveOne\u2019s intent to repurchase shares of its and/or PodcastOne\u2019s common stock from time to time under LiveOne\u2019s announced stock repurchase program and the timing, price, and quantity of repurchases, if any, under the program; LiveOne\u2019s ability to maintain compliance with certain financial and other covenants; LiveOne successfully implementing its growth strategy, including relating to its technology platforms and applications; management\u2019s relationships with industry stakeholders; LiveOne\u2019s ability to extend and/or refinance its indebtedness and/or repay its indebtedness when due; uncertain and unfavorable outcomes in legal proceedings and/or LiveOne\u2019s ability to pay any amounts due in connection with any such legal proceedings; changes in economic conditions; competition; risks and uncertainties applicable to the businesses of LiveOne\u2019s subsidiaries; and other risks, uncertainties and factors including, but not limited to, those described in LiveOne\u2019s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, filed with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d) on July 1, 2024, Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the November 14, 2024, and in LiveOne\u2019s other filings and submissions with the SEC. These forward-looking statements speak only as of the date hereof, and LiveOne disclaims any obligation to update these statements, except as may be required by law. LiveOne intends that all forward-looking statements be subject to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. For media inquiries, please contact: LiveOne IR Contact: Liviakis Financial Communications, Inc. (415) 389-4670 john@liviakis.com LiveOne Press Contact: LiveOne press@liveone.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GCTK", "date": "2024-12-10T18:53:00+00:00", "sentiment": {"score": 0.6416168548166752, "confidence": 0.6509674191474915, "probabilities": {"positive": 0.6509674191474915, "negative": 0.009350564330816269, "neutral": 0.33968204259872437}}, "embedding": [-0.07872331887483597, -0.20941150188446045, -0.045027412474155426, -0.10520835220813751, 0.0301989559084177, 0.08093956857919693, -0.06629212945699692, -0.11768697202205658, 0.042604491114616394, -0.01766056753695011, 0.026181701570749283, -0.03755718842148781, 0.0537697970867157, 0.009700887836515903, 0.05671162158250809, -0.18107552826404572, 0.12329251319169998, -0.02693406119942665, -0.12316425144672394, 0.06705755740404129, 0.04225824028253555, -0.0387420728802681, -0.04603792354464531, 0.05102260038256645, 0.1498790979385376, -0.07109254598617554, -0.07702499628067017, 0.051119595766067505, -0.07793078571557999, -0.11751087009906769, 0.1249571293592453, 0.05336867272853851, 0.027227893471717834, -0.08811577409505844, -0.17858809232711792, -0.00693376362323761, -0.05335221439599991, -0.03898557275533676, -0.0516900010406971, -0.07118313759565353, 0.036717481911182404, 0.012717285193502903, -0.11616712808609009, -0.018028633669018745, -0.06147444248199463, -0.1453005075454712, -0.11322994530200958, 0.032400380820035934, -0.019957922399044037, 0.20278143882751465, -0.1584034562110901, -0.12268269062042236, 0.1120782420039177, 0.23720112442970276, -0.09940000623464584, 0.07979775220155716, -0.031921032816171646, 0.20376843214035034, 0.07961560785770416, 0.08985640108585358, -0.025009850040078163, -0.10290561616420746, 0.05116615444421768, 0.10358551889657974, 0.041281577199697495, -0.012328221462666988, -0.025119880214333534, 0.1829560101032257, -0.1184203028678894, -0.12409849464893341, 0.07990580797195435, -0.03213277459144592, -0.10770530253648758, 0.10547405481338501, 0.10337184369564056, 0.04084097966551781, 0.13790766894817352, -0.02469438686966896, 0.07843728363513947, 0.015113091096282005, 0.03186767175793648, 0.040077704936265945, -0.20319712162017822, -0.050254784524440765, -0.016470888629555702, -0.07938362658023834, -0.08172793686389923, -0.09243336319923401, -0.022836674004793167, -0.05198439583182335, -0.13972505927085876, 0.18597382307052612, 0.04879339411854744, -0.0034680981189012527, -0.016378823667764664, 0.0766160860657692, -0.028794648125767708, 0.13596932590007782, -0.03418916091322899, 0.046594370156526566, -0.019418038427829742, 0.11145327985286713, -0.10213084518909454, -0.06695720553398132, -0.025677679106593132, -0.17282551527023315, 0.025045044720172882, 0.13184979557991028, 0.038919709622859955, 0.05584295839071274, -0.03174259141087532, 0.06549980491399765, -0.05829036608338356, -0.1455231010913849, 0.07770126312971115, 0.11546565592288971, -0.04844321683049202, 0.04722979664802551, 0.219110906124115, -0.17042019963264465, -0.0013974392786622047, 0.12066706269979477, 0.10924596339464188, -0.12172431498765945, 0.2399456799030304, -0.011885488405823708, -0.07733415812253952, 3.8386730462101534e-33, -0.004918722435832024, 0.0236832182854414, 0.015920359641313553, 0.06634528934955597, -0.004371319431811571, -0.03422605246305466, -0.07349332422018051, 0.15227434039115906, -0.17784708738327026, -0.03546837344765663, -0.06674586981534958, 0.25475454330444336, -0.09156261384487152, 0.14064618945121765, 0.08674193918704987, -0.10789714753627777, -0.11498895287513733, 0.0017829735297709703, 0.03393056243658066, -0.07659377157688141, -0.005761268548667431, 0.006680402439087629, 0.035463906824588776, 0.10127167403697968, 0.05410957336425781, -0.03391420841217041, 0.03228574991226196, -0.0541791208088398, 0.01852870173752308, 0.05982799082994461, -0.13904593884944916, -4.115886986255646e-05, 0.11352667957544327, -0.12560433149337769, -0.09753517806529999, -0.05537305772304535, -0.26217103004455566, -0.14542937278747559, -0.030329346656799316, -0.005637754686176777, -0.032064177095890045, -0.028511829674243927, -0.14899387955665588, -0.11060518026351929, -0.10365217924118042, 0.08208301663398743, -0.007354630157351494, -0.007715130224823952, 0.12888476252555847, 0.07548660784959793, 0.11947382986545563, 0.03263234347105026, -0.02809852361679077, 0.029437916353344917, -0.09582491964101791, 0.13123831152915955, -0.04999861866235733, -0.08374558389186859, 0.10530293732881546, -0.01292091142386198, -0.07457085698843002, 0.10375764966011047, -0.001765754073858261, 0.15359601378440857, -0.06078076362609863, 0.1392078697681427, 0.21262046694755554, -0.06184037774801254, 0.06952407211065292, -0.052278779447078705, -0.055416904389858246, -0.12190833687782288, 0.04986477270722389, -0.04232894629240036, -0.06422919034957886, 0.04351206123828888, -0.09579098224639893, -0.08532781898975372, 0.088581882417202, 0.02898292988538742, -0.07844117283821106, 0.00024368497543036938, -0.007258737459778786, 0.0272474754601717, 0.05882597342133522, 0.06746894121170044, 0.01940082013607025, -0.16344523429870605, -0.09839791059494019, 0.04412977769970894, -0.012667786329984665, 0.05713503807783127, -0.04469267278909683, 0.10703743994235992, 0.06399567425251007, -5.800692871219541e-33, -0.050641484558582306, -0.027993351221084595, 0.07963073253631592, -0.1162591502070427, 0.005626965314149857, -0.02639979124069214, 0.010075444355607033, -0.010681532323360443, 0.0879896730184555, -0.04759998619556427, -0.050063204020261765, -0.1800401508808136, -0.2031283974647522, 0.08825276792049408, 0.03885761275887489, -0.040973592549562454, 0.08073462545871735, -0.16392764449119568, -0.028082408010959625, 0.008260981179773808, 0.06846382468938828, 0.20195436477661133, -0.12434970587491989, 0.10090317577123642, 0.07244449108839035, -0.05946896970272064, 0.1108357384800911, 0.255440890789032, 0.22394606471061707, -0.040605053305625916, -0.009929419495165348, -0.09830859303474426, -0.12938649952411652, -0.043276168406009674, 0.13446763157844543, 0.16092449426651, 0.07028672099113464, -0.03353818878531456, -0.007425637915730476, -0.11388839781284332, 0.024042651057243347, -0.0813932940363884, -0.049679823219776154, 0.01597912237048149, 0.0067269569262862206, -0.015097985044121742, -0.08214578032493591, 0.019885143265128136, -0.14737144112586975, 0.037785135209560394, 0.07553310692310333, 0.1195736974477768, -0.00604407861828804, 0.06394995748996735, -0.06552853435277939, -0.05045028775930405, -0.09952139109373093, 0.08831348270177841, -0.028435347601771355, -0.07776118069887161, 0.10861058533191681, 0.038838908076286316, -0.05912179499864578, 0.0007139639928936958, 0.015195785090327263, 0.025985652580857277, 0.1004582941532135, -0.09290473163127899, -0.17747442424297333, 0.0083093773573637, 0.1350434571504593, -0.07822968810796738, -0.0653093010187149, -0.18438269197940826, -0.2024725079536438, 0.011293847113847733, -0.17274025082588196, -0.030827248468995094, -0.04554159194231033, -0.032856959849596024, -0.027549175545573235, 0.0836467295885086, 0.1066431999206543, 0.03003789111971855, 0.08558829128742218, -0.013239990919828415, 0.027841346338391304, 0.020213264971971512, 0.04947493225336075, 0.10851064324378967, 0.005865835584700108, -0.02315654046833515, -0.19643676280975342, 0.032553013414144516, -0.059193260967731476, -1.008931178603234e-07, 0.05495167523622513, 0.04560871422290802, 0.011470689438283443, -0.04786374792456627, 0.03820304572582245, -0.05000663548707962, 0.0968838781118393, -0.004788268357515335, 0.0702057033777237, 0.1607241928577423, 0.17974652349948883, -0.03110429458320141, -0.11673082411289215, 0.03495687618851662, -0.02344498410820961, -0.057020820677280426, -0.15571610629558563, 0.06472853571176529, -0.07487116008996964, 0.005728469230234623, -0.040679145604372025, 0.1384764313697815, -0.04139484465122223, -0.1038726419210434, 0.04016219824552536, -0.03495064005255699, 0.10601381957530975, 0.07814019918441772, 0.10066363960504532, -0.07491141557693481, -0.04945094883441925, -0.04868125915527344, 0.03598342090845108, -0.0736779272556305, -0.00662264134734869, -0.08627539128065109, 0.09011414647102356, 0.03812386840581894, 0.014363659545779228, 0.11396226286888123, -0.04325292259454727, -0.04607657715678215, 0.03394583985209465, 0.005536748096346855, -0.06826258450746536, -0.0006506075151264668, -0.07540479302406311, -0.013260449282824993, 0.19219154119491577, 0.023526255041360855, -0.16471587121486664, -0.07598454505205154, -0.03594142571091652, -0.09318698942661285, 0.0024202584754675627, -0.024765033274888992, -0.0027064813766628504, 0.059729233384132385, 0.018238378688693047, 0.1491607278585434, 0.14570435881614685, -0.01953939162194729, 0.12793749570846558, 0.12469123303890228], "changes": {"1wk": -13.288918259293581, "1mo": -51.33239788315734}}]